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BACKGROUND
Introduction
Smith-Magenis syndrome (SMS; OMIM# 182290) is a genetic disorder
characterized by multiple congenital anomalies and mental retardation most commonly
caused by a 3.7- Mb deletion on human chromosome 17p11.2. In addition, mutations in the
RAI1 gene have also been described as a cause of SMS (Greenberg et al., 1996, Slager et al.,
2003). Smith-Magenis syndrome was first described in 1982 and has an estimated
prevalence of 1/25,000 births (Greenberg et al., 1991). Since its first description in 1982 and
the publication of the spectrum of clinical features by Smith et al. in 1986, the more subtle
features of this syndrome have been delineated. Individuals with SMS encompass a
phenotypic spectrum that includes congenital anomalies, characteristic craniofacial features,
growth abnormalities, mental retardation and a distinctive neurobehavioral profile.
History of Smith-Magenis syndrome
The first official account of what is now known as Smith-Magenis syndrome was
published in the American Journal of Human Genetics in 1982. Smith et al. reported two
unrelated males with facial clefts and congenital heart disease. The first individual carried a
diagnosis of Pierre Robin sequence, a ventricular septal defect (VSD), congenital heart
block, skeletal abnormalities and hearing loss (Smith et al., 1986). Individual number one
died at six months of age from complications related to surgical repair of his VSD (Smith et
al., 1986). The second individual had bilateral cleft lip and palate and VSD. Both of the
individuals were diagnosed with failure to thrive (FTT) and were less than the 3rd percentile
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for their growth parameters. Cytogenetic analysis revealed that both of these individuals
had an interstitial deletion of the p11 band on chromosome 17 (Smith et al., 1982).
A follow-up article published in 1986 by Smith et al. provided detailed case reports
of seven newly identified and two previously identified individuals with congenital heart
defects and facial clefts. Cytogenetic analysis of these nine cases revealed, all had at a
minimum, a small interstitial deletion in 17p11.2 and individual 1, the most severely
affected of the cases reported, was deleted for the entire 17p11.2 band (Smith et al., 1986).
The phenotypes of the individuals were compared and the majority of individuals had the
following: brachycephaly, midface hypoplasia, broad nasal bridge, prognathism, short
stature, scoliosis, speech delay, behavior problems and mental retardation (Smith et al.,
1986).
Smith et al. 1986 were the first to report that the prognathism present in SMS
individuals is “age dependent.” They observed the two youngest patients in their cohort had
micrognathia, where as prognathism was present in the older patients. The most commonly
described features included: speech delay, which was present in seven of eight (87.5%)
living patients, a hoarse deep voice was identified in four of eight (50%) individuals and
hearing loss was present in six of nine (66.67 %) individuals. They also found that seven of
eight (87.5%) living individuals had similar behavioral problems that began in early
childhood including hyperactivity and self-destructive behaviors (Smith et al., 1986).
At the time of the Smith et al. publication in 1986, there were seven additional
individuals with 17p11.2 deletions with similar phenotypes to those described by Smith et
al. reported in the medical literature (Patil and Bartley, 1984; Stratton et al., 1986.) Since

2

the initial publications by Smith et al., several different groups of researchers have
contributed invaluable information to the field of SMS research. One of these such groups
was lead by Doctors Greenberg and Lupski at Baylor College of Medicine and Texas
Children’s Hospital through a multidisciplinary clinical study of individuals with SMS. The
results of this study, published by Greenberg et al. in 1991 and 1996, provided phenotypic
information on a cohort of individuals with SMS. Their examination of individuals with
SMS confirmed the common clinical features and provided information on features that had
never been reported in individuals with Smith-Magenis syndrome.
Since 1997 another group of researchers at the NIH/NHGRI have been conducting a
study of the natural history of SMS with the goals of further characterizing the phenotype to
ensure increased recognition of the syndrome and earlier diagnosis. They have also been
working to develop therapies and interventions to treat the developmental delays and
behavioral abnormalities seen in individuals with SMS. The 2006 publication by Gropman
et al. provided a comprehensive review of the SMS phenotype using data collected from the
NIH natural history study.
Clinical Findings
Congenital Anomalies
Although congenital anomalies are not present in all individuals with SMS, the most
common congenital anomalies are cleft lip with or without cleft palate, renal/urinary tract
abnormalities and cardiac defects. Renal abnormalities were present in two of nine (22 %) of
individuals studied by Smith et al. 1986. One individual was found to have bilateral
ureterovesicular obstruction and a second individual was found to have a single hypertrophic
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right kidney with malposition of the ureterovesicular junction. The prevalence of renal and
urinary tract abnormalities in the Greenberg SMS cohort was 34.6% and included the
following abnormalities: duplication of the collecting system, unilateral renal agenesis and
ectopic kidney (Greenberg et al., 1996). Due to the high prevalence of renal and urinary tract
abnormalities, renal ultrasounds should be performed following a diagnosis of SMS to
ensure appropriate treatment and surgical correction if necessary.
Five out of twelve (43%) individuals studied by echocardiography by Greenberg et
al., 1996 were found to have cardiac anomalies that included: mild tricuspid regurgitation,
mild mitral regurgitation, subvalvular aortic stenosis, VSD and supravalvular pulmonic
stenosis. Four individuals had been diagnosed with a cardiac abnormality previously and
these abnormalities included pulmonic stenosis, VSD, mitral valve prolapse and an ASD.
Ten of twenty-seven (37%) individuals evaluated in the Greenberg SMS cohort were found
to have cardiac anomalies. Due to the high prevalence of congenital heart defects in
individuals with SMS, echocardiogram should be performed following the initial diagnosis
and if a heart defect is identified, surgical repair is indicated.
Craniofacial
The facial appearance of individuals with SMS, though distinct, can vary between
infancy and adulthood. Infants with SMS may only display subtle dysmorphic facial
features including a broad, square shaped face with mid-face hypoplasia, while adolescents
and adults with SMS show more pronounced dysmorphic facial features (Gropman et al.,
2006). In addition to the broad, square-shaped face, adults with SMS can have
brachycephaly, midface hypoplasia, tented upper lip, up-slanting palpebral fissures, deep-set
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eyes, short full-tipped nose and prognathism (Greenberg et al., 1991). The facial features
present in adults with SMS have also been described as coarse with deep-set eyes, relative
prognathism, heavy brows and synophyrs (Allanson, Greenberg, & Smith, 1999)
Growth and Development
To assess the SMS phenotype during infancy Gropman, Duncan & Smith (2006)
performed medical histories and physical exams, and analyzed parent questionnaires and
medical records of patients 24 months or older. They found that the weight, length and
FOC of infants with SMS are within normal limits at birth. However, at approximately 12
months of life, infants with SMS begin to show features of failure to thrive (FTT) including
poor weight gain and poor linear growth (Gropman, Duncan, & Smith, 2006; Greenberg et
al., 1991). The FTT was thought to be related to the oral motor dysfunction present in all
infants studied as well as hypotonia, lethargy, increased sleepiness and daytime napping
(Gropman, Smith, Allanson, & Greenberg, 1998). It was also reported that all infants
studied showed some degree of oral motor dysfunction, with poor feeding being present in
some (Gropman, Duncan, & Smith, 2006).
All infants studied by Gropman, Duncan & Smith., in their 2006 publication also had
motor delays and decreased crying and babbling but were within normal limits, or only
slightly delayed for their social-emotional function.
Sleep Disturbances
Prior to childhood, the sleep patterns of infants with SMS are not characterized as
problematic or troublesome. In fact, many parents of SMS infants describe them as “perfect
babies” (Gropman et al., 2006). It is during childhood that characteristic sleep disturbances
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of SMS become evident. However, retrospective analysis has found sleep abnormalities are
present in infants with SMS (Greenberg et al, 1991). Infants with SMS have “excessive
daytime sleepiness” and decreased 24-hour sleep (Greenberg et al., 1991). In the Greenberg
et al. 1991 cohort, 62% of individuals showed signs of a sleep disorder that included
difficulty falling asleep, staying asleep, and frequent awaking during the night. They also
reported that REM sleep was absent in two individuals studied by polysomnography. In
1996, Greenberg et al., reported of the 24 individuals who underwent sleep studies, 29%
patients had decreased sleep time due to frequent night-time awakening. Decreased rapid
eye movement (REM) sleep was found in 12 of 24 (50%) individuals, normal REM sleep
was found in 11 of 24 (45.8%) individuals and one patient (4 %) had increased REM sleep.
Greenberg et al. reported all individuals studied had problems falling and staying asleep
throughout the night. They concluded that there was a defect in REM sleep but were unsure
of the underlying mechanism.
DeLeersnyder et al., in 2001 measured the plasma concentrations of melatonin over a
24-hour period in 20 subjects with SMS as well as their age matched controls. Their results
showed individuals with SMS had different melatonin cycling when compared to their age
matched controls. Typically the circadian rhythm functions such that melatonin is low
during the day light hours, however as darkness sets, the pineal gland begins to produce
melatonin indicating to the body that it is time to sleep. In individuals with SMS, their
melatonin secretion began at 6 AM + 2 hours, their levels peaked at 12 PM + 1 hour and
their offset occurred at 8 PM + 1 hour (DeLeersnyder et al., in 2001). This is in contrast to
the melatonin cycling seen in their age matched controls who experienced onset of secretion
at 9 PM + 2 hours, peak of secretion at 3:30 AM + 1.30 hours and offset of melatonin at 6
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AM + 1 hour. DeLeersnyder et al., also found a positive correlation between the frequency
of a SMS child’s tantrums and increasing daytime melatonin levels. As the amount of
melatonin increased during the day, the frequency of tantrums in individuals with SMS
increased as well. DeLeersnyder et al. hypothesized the behavioral problems could be
aggravated by the fact that children with SMS have elevated melatonin levels during the
daytime and that their daytime sleepiness could be causing or contributing to their
behavioral problems.
Since these abnormalities in melatonin cycling have been discovered, researchers
have attempted to treat the sleep disturbances by using melatonin and acebutolol an oral
beta-1-adrengeric antagonist. A trial conducted by De Leersynder et al. in 2003 studied the
daytime usage of acebutolol and an evening dose of 6 mg of melatonin. This dosage pattern
was able to increase the nocturnal melatonin levels, improve nighttime sleep and decrease
daytime sleepiness and improve overall daytime behavior (Leersynder et al. in 2003).
The sleep disturbances present in children with SMS present a management
challenge. No well controlled treatment trials have been conducted. There is currently no
standard of care or management protocol to control the sleep disturbances in children with
SMS.
Neurobehavioral
The neurobehavioral abnormalities present in SMS are a distinctive component of its
clinical phenotype. Self-destructive behavior was present in 67% of individuals described
by Greenberg et al. in 1991. The neurobehavioral profile of 29 individuals with SMS was
studied and self-injurious behaviors were present in 96.6% of individuals (Finucane, Dirrigi,
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& Simon, 2001). Individuals with SMS exhibit the following: hyperactivity, sleep
disturbances, temper tantrums, attention seeking, self-hitting, self-biting, self-hugging,
polyembolokoilamania (inserting foreign bodies into body orifices) and onychontillomania
(pulling out one's fingernails) (Greenberg et al., 1991). Greenberg et al. also reported selfdestructive behaviors such as head banging and wrist biting are present as early as 2 years of
age; but, more severe behavior such as onychotillomania does not present until 5-6 years of
age. The stereotypic and self-injurious behaviors present in SMS are so unique that they are
a major clue for diagnosis as they are distinguishable from other genetic syndromes
associated with mental retardation. There is a direct correlation between the severity of selfinjurious behaviors and the level of intellectual functioning in individuals with SMS
(Finucane, Dirrigi, & Simon, 2001).
SMS shares common features with those seen in Prader-Willi syndrome (PWS;
OMIM 176270) and before much was known about SMS, some individuals with SMS were
misdiagnosed as having PWS (Dykens & Smith, 1998). As first published by Greenberg et
al., the overlapping features of PWS and SMS include the following: infantile hypotonia,
short stature, skin picking, sleep disturbances and behavioral abnormalities. Greenberg et
al., 1996 also noted that individuals with SMS also have hyperphagia (Greenberg et al.,
1996b). Although there continues to be overlap of the PWS and SMS phenotypes, there are
certain features now know to be unique to each of these syndromes (Dykens & Smith,
1998). In a study comparing the neurobehavioral abnormalities of PWS and SMS,
individuals with PWS were found to have higher levels of obsessive food related thoughts
(Dykens & Smith, 1998). SMS individuals were also found to show obsessive thinking but
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these thoughts were not necessarily always realted to food and were more often related to
“specific topics or events” (Dykens & Smith, 1998).
Cognitive
Although varying degrees of mental capacity are seen, adolescents and adults with
SMS continue to experience cognitive delays and the majority of individuals have moderate
mental retardation (Greenberg et al. 1991). Behavioral abnormalities continue to become
more pronounced during adolescence and remain constant throughout adulthood.
Adolescents with SMS experience aggressive and explosive outbursts, attention seeking
behaviors and impulsive, disobedient actions. They continue to engage in the self-injurious
behaviors that began in childhood (Dykens & Smith, 1998).
Most individuals with SMS are not able to live on their own as adults and require
supervision from caregivers to ensure that their daily needs are met. Lifespan is not thought
to be different than other individuals with mental retardation and there is no decline in
cognitive abilities (Dykens and Smith 1998). The oldest individual known to have SMS
died at the age of 88 from a stroke (http://www.ncbi.nlm.nih.gov/sites/GeneTests; 04/09/10).
As part of the multidisciplinary study conducted by Greenberg et al., imaging
studies were performed on individuals with SMS to determine whether or not brain
malformations contributed to their neurobehavioral phenotype and mental retardation. Brain
MRI showed abnormalities in 13 individuals that included findings of ventriculomegaly and
enlarged cisterna magna; both of which were considered clinically insignificant (Greenberg
et al., 1991, Greenberg et al., 1996a). Based on these insignificant findings, researchers

9

were able to conclude the cognitive impairments and behavioral abnormalities in individuals
with SMS were not attributed to brain malformations.
Other Phenotypic Findings
The following describes abnormalities that are occasionally seen in individuals with
SMS and warrant evaluation during annual physical examination. Ophthalmologic
abnormalities were seen in 23 out of 27 individuals studied by Greenberg et al in 1991.
These abnormalities included strabismus, myopia, microcornea, iris dysplasia, nasal
corectopia and iris coloboma. Hearing loss has also been described in individuals with
SMS, therefore periodic audiologic evaluation is recommended. Of twenty-five patients who
underwent audiologic evaluations 10 individuals were found to have conductive hearing
loss, 5 were found to have sensorineural hearing loss and 2 had mixed hearing loss; giving a
combined prevalence of hearing impairment of 68% (Greenberg et al., 1991; Potocki,
Shaw, Stankiewicz, & Lupski, 2003)). Hearing loss was also present in the two individuals
first described with SMS (Smith et al., 1982). Individuals with SMS can also develop
scoliosis. Mild to moderate thoracic scoliosis was present in 13 of 20 or 65% of patients
greater than 4 years of age (Greenberg et al., 1991; Potocki, Shaw, Stankiewicz, & Lupski,
2003). More recent data suggests that vertebral anomalies and scoliosis are present in
approximately 60% of SMS individuals and thus spine radiographs are needed to evaluate
for these conditions.
Diagnosis
The diagnosis of SMS was first made using routine G banded cytogenetic
techniques. However this method missed a large number of deletions that were not visible
10

using standard cytogenetic technology. Fluorescence in-situ hybridization (FISH) was able
to identify smaller deletions in 17p11.2. With the development of array comparative
genomic hybridization (array CGH), many individuals with smaller deletions in 17p11.2 that
would have been missed using FISH technologies have been identified on array CGH.
Array CGH, also known as chromosomal microarray or whole genome array has now
become the primary method of diagnosis of SMS. Even with the advances that have been
made in array CGH technologies, there remains a subset of patients who meet SMS clinical
criteria who do not have identifiable deletions of 17p11.2. In individuals with the clinical
phenotype of SMS without identifiable deletions in 17p11.2, mutation analysis of the RAI1
gene should be performed.
Genetics of Smith Magenis syndrome
Smith-Magenis syndrome (SMS; OMIM# 182290) is a genetic disorder that is
caused by a deletion on human chromosome 17p11.2 or a mutation in the RAI1 gene
(Greenberg et al., 1996, Slager et al., 2003). SMS is thought to be continguous-gene
deletion syndrome (CGS). Contiguous-gene deletion syndromes can cause both
microduplications and microdeletions due to misalignment of homologous chromosomes.
Although both small (approximately 1.5 Mb) and large (approximately 9 Mb) deletions of
17p11.2 have been reported in SMS patients, 75% of individuals have a common 3.5 Mb
deletion in this region (Trask et al., 1996). The minimum deletion region is approximately
700 kB in size (Girirajan et al., 2005). In addition, it is also known that mutations in the
RAI1 gene result in an SMS phenotype (Slager et al., 2003.)
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Low Copy repeats
In 1997 Chen et al., discovered homologous recombination between flanking SMSREP repeat-gene clusters was the molecular basis for the SMS common deletion. Low copy
repeats have been implicated in the molecular basis of several genetic conditions including
DiGeorge/velo-cardialfacial syndrome, Prader-Willi/Angelman syndrome and Williams
syndrome. Genetic diseases, caused by microdeletions or microduplications occur when
there is nonallelic homolgous recombination (NAHR) between the low-copy repeats (LCR)
gene clusters during maternal and paternal gametogenesis (Erdogan, Chen, Kirchhoff et al.,
2006).
Discovery of RAI1
Girirajan et al., (2005) were able to define the critical region of SMS to a ~700 kb
region that was commonly deleted in all SMS patients with deletions in 17p11.2. Further
study of this region led researchers to discover that there were small deletions present within
the RAI1 gene in patients who did not have deletions in 17p11.2 detectable by FISH (Slager
et al 2003). In 2003 it was discovered that dominant frameshift mutations in the retinoic
acid inducible 1(RAI1) gene were present in three individuals who had clinical features of
SMS but did not have 17p11.2 deletions present (Slager et al., 2003). Further studies have
identified additional individuals with the “hallmark” clinical features of SMS including
developmental delay, sleep disturbances and self injurious behavior with deletions in RAI1.
In 2005, Girirajan et al. summarized the findings of all of the individuals found to have
mutations in RAI1 and found that none of these individuals with RAI1 mutations had the less
common features seen in individuals with SMS including heart defects, urinary system
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malformations or other birth defects. These data lead researchers to postulate that
haploinsufficiency of RAI1 is responsible for the behavioral, neurological, otolaryngological
and craniofacial features of SMS and more variable features including congenital defects are
caused by hemizygosity of other genes in the 17p11.2 region (Slager et al., 2003).
RAI1
At the time of its discovery in 2003, researchers were uncertain of the clinical roles
of RAI1. Since 2003, researchers have discovered the RNA product of RAI1 is expressed in
all tissues studied and was present in high levels in the heart and neuronal structures (Slager
et al., 2003; Toulouse, Rochefort, Roussel, Joober, & Rouleau, 2003). The RAI1 gene is
highly conserved throughout mammalian evolution. The current hypothesis regarding the
function of the RAI1gene is that RAI1 is a transcriptional regulator involved in the
development of neurons but its exact function is unknown (Girirajan et al., 2005).
SMS Mouse Models
Mouse models of SMS, del(17)(p11.2p11.2) and the Potocki-Lupski syndrome,
dup(17)(p11.2p11.2) (PTLS; OMIM#610883) the recombination reciprocal of the SMS
deletion, have been created to further understand the phenotypes of the two syndromes.
Human chromosome 17p11.2 is syntenic to a 32-to-34 cM region on mouse chromosome 11.
The critical interval for SMS is a ~1-Mb region that includes 19 genes that are conserved in
the same order and orientation in mice (Bi et al., 2002). Studies performed in the SMS mice,
Df(11)17/+ and the PTLS mice, Dp(11)17/+ have demonstrated differences in the growth
patterns consistent with what is reported in humans with SMS and PTLS.
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An important finding of studies of mice with SMS and PTLS are the differences in
body weight first reported by Walz et al., in 2003. During the first month of life the
Dp(11)17/+ and Df(11)17/+ mice were both significantly lower in weight when compared
to their wild-type litter mates. The PTLS mice, Dp(11)17/+, remained underweight
throughout their lives and the homozygous duplication mice Dp(11)17/Dp(11)17 were
significantly underweight, even compared to the heterozygous duplication mice,
Dp(11)17/+. Starting at 4 months of age, the SMS mice Df(11)17/+, were significantly
overweight when compared to the wild-type mice. By 8 months of age the Df(11)17/+ mice
weighed more than 60g, whereas the wild-type mice weighed approximately 30g. The
abdominal fat contents were also compared between the different genotypes. The
Df(11)17/+ mice had an average abdominal fat content of 1.93 + 0.20g. The Dp(11)17/+
mice had an average abdominal fat content of 0.30g + 0.06g and the wild-type mice had an
average abdominal fat content of 0.56g + 0.05g. The amount of abdominal fat made up 4.5%
of the total body weight in Df(11)17/+ mice, 1.2 % of the total body weight of the
Dp(11)17/+ mice and 2.0% of the total body weight of the wild-type mice. When the
Df(11)17/ Dp(11)17 mice were studied they were found to have weights similar to that of
the wild-type mice. This finding suggests that the presence of the wild-type number of genes
can rescue the overweight phenotype of the Df(11)17/+ mice and the underweight
phenotype of the Dp(11)17/+ mice (Walz et al., 2003.
In addition to describing the weight differences between the deletion and duplication
mice, there is also data available about other phenotypic characteristics. It is known that the
craniofacial features of SMS become more pronounced as an affected individual ages. The
craniofacial features of the Df(11)17/+ mice have been documented throughout the life span
14

of the mouse. No craniofacial abnormalities were appreciated during the newborn period of
Df(11)17/+ mice when compared to wild-type mice. All of the adult Df(11)17/+ mice were
found to have craniofacial abnormalities including shorter skull lengths, broader and shorter
snouts and distinctive nasal bone shape. Congenital heart defects, urinary tract defects and
seizures have been reported in 35%, 29% and 19% of individuals with SMS respectively
(Chen et al., 1997 and Greenberg et al., 1996). No defects were found in the heart or urinary
system of Df(11)17/+ or Dp(11)17/+ mice. Seizures and abnormal EEGs were present in
Df(11)17/+ mice. This finding led researchers to postulate that there was a direct effect of
the deletion on neuronal excitability (Walz et al., 2003). Seizures were not present in the
Dp(11)17/+ mice.
Before haploinsufficiency of RAI1 was determined to be responsible for major
features of SMS, a mouse model with a null mutation in RAI1 was created to study the
relationship between the RAI1 copy number and the Df(11)17/+ and Dp(11)17/+
phenotypes. The weights of the Rai1+/- mice were measured from 3 weeks to 7 months. At
4-7 weeks of age the Rai1+/- mice were underweight when compared to their wild-type
litter mates. However, by 23 weeks of age both male and female Rai1+/- mice were
overweight when compared to their wild-type littermates. Researchers were able to
conclude that haploinsufficiency of Rai1 was a major factor in the obesity that is present in
SMS individuals (Bi et al., 2005).
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Obesity
In the General Population
The negative health, economic, and social consequences of obesity are well
documented. The American Medical Association considers obesity the fastest growing
health problem in the United States. Obesity kills more than 300,000 Americans per year,
which is more than AIDS, all cancers and all accidents combined. More than 66% of the
adult population in the United States is overweight or obese (Ogden, Carroll, Curtin,
McDowell, Tabak, & Flegal, 2006). More frightening than the facts about obesity in US
adults, are the statistics about overweight and obese children. The prevalence of overweight
and obesity in US children has tripled over the past two decades (Ogden, Carroll, Curtin,
McDowell, Tabak, & Flegal, 2006)
Overweight and obesity have been shown to increase morbidity/mortality and
decrease life expectancy. The health risks associated with obesity include: insulin
resistance, type 2 diabetes, hyperlipidemia, hypertension, coronary heart disease, congestive
heart failure and gastrointestinal complications including gastroesophageal reflux, gallstones
and gallbladder disease, gout and non-alcoholic fatty liver disease (Pi-Sunyer, 1991).
Overweight and obese individuals are at increased risks for developing certain types of
cancer including: endometrial, colon, kidney, gallbladder and postmenopausal breast cancer
(Krebs et al., 2007). In addition to the physical risks associated with overweight and
obesity, there are also emotional and psychosocial risks that are often under appreciated.
Overweight and obese individuals have increased risks for depression, low self-esteem, poor
self-image and social isolation (Krebs et al., 2007).
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As with most health conditions, family history is important in determining a child’s
risk to develop obesity and the strongest predicator of childhood obesity is the weight status
of the parents. If one parent is obese, the odds ratio that a child will be obese as an adult is
3:1. This odds ratio jumps to 10:1 if both parents are obese (Whitaker, Wright, Pepe, Seidel,
& Dietz, 1997). It is thought that the relationship between parental and childhood obesity is
multi-factorial in etiology, with multiple genes and environmental factors playing a role.
Genome wide association studies have been performed to gain more information about
genes that are associated with obesity. The results of these studies showed that obesity is
polygenic, with more than 300 genes and genetic loci associated with obesity (Chagnon,
Rankinen, Snyder, Weisnagel, Perusse, & Bouchard, 2003). Additionally, there are 50 loci
related to Mendelian syndromes associated with obesity that have been mapped (Rankinen,
et al., 2006).
In Genetic Conditions
It is well documented that obesity and food seeking behaviors are present in certain
genetic conditions associated with cognitive impairment. Prader- Willi syndrome (PWS;
OMIM 176270) is an example of a genetic condition that is primarily associated with
obesity, cognitive impairments, maladaptive behaviors and hyperphagia, an abnormally
increased appetite for and consumption of food (Dykens, Maxwell, Pantino, Kossler, &
Roof, 2007).
Although the negative effects of obesity in the general population are well known,
little is known about the prevalence or cause of any obesity that is present in the SMS
population. In more recent studies of SMS individuals, a new concern for the involvement
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of obesity has been raised. Of those studies that have been published, information obtained
was often incomplete and small in number. Because so little is available, it is not clearly
defined how obesity is involved in the natural history of this condition.
An abstract presented by Smith et al. in 2004 provided an overview of parametric
measurements of growth and body mass index (BMI) of 54 individuals with SMS. BMI is a
measurement of weight in relation to height that is used to determine if an individual is
overweight or obese. BMI is calculated in the following manner: BMI= weight (kg)/height
(m2). In adults, normal weight is defined as a BMI between 18.5- 24.9, underweight is
classified as a BMI less than 18.5, overweight is defined as a BMI of 25-29.9 and obesity is
defined as a BMI of 30 or greater. In the abstract presented by Smith et al., the mean birth
weight was between the 5th -25th percentile and birth length was between the 25th- 50th
percentiles. They reported that poor growth, as defined by <5th percentile, was noted within
the first six months of age and that it may persist into early childhood. The abstract also
reported that on average, males with SMS were at the 25th percentile for weight at age 6
years and grew to the 90th percentile by 14 years. Females with SMS were reported to be
between the 25-50th percentile for weight between the ages of 1- 7 years and increased to
>90th percentile by age 12 (Smith, Leonard, Gropman, & Krashewich, 2004). Another study
investigating hypercholesterolemia in 49 individuals with SMS reported the mean BMI in
individuals with SMS was 18.43 with a range of 14.08- 31.67 (Smith, et al., 2002). A metaanalysis of 105 individuals with SMS published in 2007 provided valuable information
about genotype-phenotype information in individuals with SMS (Edelman, et al., 2007).
However information regarding growth and BMI was unavailable for over 60% of the cases
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examined. Because of these conflicting findings, further studies regarding the role of obesity
in the Smith-Magenis population are needed.
The severe neurobehavioral abnormalities present in individuals with SMS make this
facet of the phenotype an interesting avenue to explore in an attempt to provide an
explanation of the obesity seen in individuals with SMS. Therefore the specific aims of this
study are to:
1.) Characterize the growth (height, weight and BMI) of a cohort of individuals with
Smith-Magenis syndrome to determine if obesity is a component of SMS in our
patient population.
2.) Assess if hyperphagia or food seeking behaviors are present in individuals with
Smith-Magenis syndrome.

Determining whether or not neurobehavioral abnormalities such as food seeking
behaviors and hyperphagia are present in individuals with SMS would aid in further
characterizing the natural history of this genetic syndrome. In addition, if obesity and
behavioral components can be characterized, targeted and age appropriate therapies can be
developed in order to better manage individuals with SMS.
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MATERIALS & METHODS
This study used two methods of data collection in order to addresses the two specific
aims. Part I of the study aims to characterize the growth (height, weight and BMI) of a
cohort of individual with Smith-Magenis syndrome to determine the prevalence of obesity
through the use of a retrospective chart review. Part II of this study aims to assess if
hyperphagia or related behaviors are present in individuals with SMS through the use of a
parent questionnaire which includes a validated instrument, the Hyperphagia Questionnaire
(Dykens et al., 2007). This study was approved by the University of Texas Health Science
Center Committee for the Protection of the Human Subjects (HSC-GEN-09-0393) and the
Institutional Review Board for Baylor College of Medicine and Affiliated Hospitals (H25766). A consent form was required and was mailed to participants along with the study
questionnaire.
Participants
There were essentially two different sets of participants in this study. For Part I of
the study, the retrospective chart review, participants were individuals with a confirmed
medical diagnosis of Smith-Magenis syndrome by chromosome analysis, fluorescence in
situ hybridization (FISH) or array CGH (aCGH). For Part II of the study, the assessment of
hyperphagia and related food seeking behaviors, all participants were parents or caregivers
of individuals with a confirmed medical diagnosis of Smith-Magenis syndrome.
Participants were ascertained through a database of SMS patients maintained by Baylor
College of Medicine (BCM) at Texas Children’s Hospital (TCH). All participants whose
child carried a confirmed medical diagnosis of SMS had either:
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1.) Participated in or contacted researchers regarding participation in clinical
research at BCM/TCH, or:
2.) Have been, or are, currently followed in the genetics clinic at Texas Children’s
Hospital
Individuals without a confirmed medical diagnosis of SMS were not included in the
retrospective chart review, nor were their parents mailed a study questionnaire.
Procedure
In Part I of this study, a retrospective chart review was conducted of participant’s
medical records. Sources of available information included: electronic medical record,
paper charts and research charts. All documented height and weight measurements were
abstracted for each individual. This data was collected by hand, matched with the
individual’s unique study ID and entered into an Excel database.
For Part II of this study, a questionnaire was mailed to the corresponding parents of
individuals in Part I of the study. Each household was limited to one questionnaire and the
questionnaire was to be filled out by only one parent/caregiver. A total of eighty-nine
questionnaires were mailed; twenty-two questionnaires were returned without a forwarding
address for a total of seventy-seven potential participants. Twenty-five completed
questionnaires were returned, corresponding to a response rate of 28% (25 out of 89).
Questionnaires were initially mailed in October 2009 and data was collected through March
2010.
The questionnaire consisted of 51 questions subdivided into five sections. Section 1,
a set of 10 demographic questions, provided demographic information regarding the parent
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completing the questionnaire. The remaining four sections of the questionnaire provided
information regarding the individual with SMS. Section 2 consisted of 15 medical and
social history questions, Section 3 consisted of 3 exercise history questioned and Section 4
consisted of 10 diet history questions. The final 13 questions were taken from a validated
hyperphagia questionnaire (HQ), developed by Elizabeth Dykens, PhD.
The HQ was initially developed to assess hyperphagia in individuals with Prader-Will syndrome (PWS) (Dykens, Maxwell, Pantino, Kossler, & Roof, 2007). This
questionnaire has been validated in the Prader-Willi population and has also been used in
individuals with Down syndrome and undiagnosed intellectual disabilities who show food
seeking behaviors or “Prader--Willi-like” preoccupations with food. Dr. Dykens has given
permission via email for the use of the hyperphagia questionnaire in this research project.
The HQ was created to measure hyperphagia in individuals with PWS by looking at the
following: specific food related behaviors, preoccupations and thoughts about food and the
severity of the symptoms. Responses on the HQ are rated on a 5 point scale (1 = not a
problem to 5 = severe and/or frequent problem.) In their initial publication describing the
use of the HQ in 153 individuals with PWS, Dykens et al. conducted a factor analysis and
found three factors emerged which accounted for 58.93% of the variance seen in
hyperphagia (Dykens, Maxwell, Pantino, Kossler, & Roof, 2007). These factors were
labeled, Hyperphagic Behavior, which accounted for 34.47% of the variance (eigenvalue =
3.79, Cronbach’s alpha = 0.76), Hyperphagic Drive, which accounted for 15.28% of the
variance (eigenvalue = 1.68, Cronbach’s alpha of 0.80) and Hyperphagic Severity which
accounted for 9.17% of the variance (eigenvalue = 1.01, Cronbach’s alpha = 0.60). There
were two questions on the questionnaire that did not load onto any factor and these items
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were: age of onset of hyperphagia and variability in the drive for food. As these items did
not specifically correlate with factor, they were dropped from further analysis (Dykens et al.,
2007).

Individuals who completed and returned the questionnaire were eligible to receive a
$15 gift certificate to Target®. The financial support for this project (including postage, the
printing of study related materials and incentive) was provided by a donation received by
Dr. Potocki to investigate obesity in individuals with SMS.

Analysis:

Part I- Retrospective Chart Review

Based on their age at their last recorded measurement, individuals were categorized
into age groups using the classifications provided by the CDC. Table 1 provides an
overview of the age classification system used in this study.
Table. 1 Age Classifications
Age Group
Corresponding Age
1
0-23 months
2
2-5 years
3
6-11 years
4
12-19 years
5
≥ 20 years
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Z-scores
For all growth measurements, including those obtained from the parent questionnaire
and chart review, Z-scores (SD units) for height-for-age, length-for-age and BMI-for-age
were calculated using the reference growth standards provided by National Center for
Health statistics and the Centers for Disease Control and Prevention (Statistics, N.C.f.H.,
2000). The calculation of Z-scores allowed for comparison between the SMS patient
population and the reference standard as defined by the CDC. For individuals less than 20
years of age, the Z-scores were calculated using the values provided by the CDC
corresponding to their given age and gender. For individuals greater than or equal to 20
years of age, Z-scores were calculated using the values provided by the CDC corresponding
to that of a nineteen year old of their respective gender. One sample t-tests were run to
assess for differences in the weight-for age, height for age and BMI-for age Z-scores
between our SMS cohort and reference standards.
BMI
BMI was calculated for all individuals ≥ 24 months of age using the following
formula: BMI = weight (kg)/ [height(m)2]. For individuals < 20 years of age (age 24
months through 19 years of age) BMI and BMI percentile were calculated. It was necessary
to calculate BMI percent in order to interpret the BMI of individuals less than 20 years of
age, as the interpretation of BMI during childhood and adolescence is different than the
interpretation of BMI in adulthood. The interpretation of BMI in childhood is dependent on
age and gender. For individuals greater than 20 years of age, BMI was calculated and
interpreted using the CDC’s recommendation for the interpretation of BMI in adults.
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Through the use of BMI, individuals were classified as underweight, healthy weight,
overweight or obese. Table 2 provides an explanation of the interpretations of BMI in
individuals’ ≥ 2 and < 19 years of age. Table 3 provides an explanation of the
interpretations of BMI in individuals’ ≥ 20 years of age.

Table 2. BMI-for-Age
Individuals age ≥ 2 years & < 20 years of age
Weight Status
Percentile Range
Category
Underweight
< 5th percentile
Healthy weight
5th percentile through <
85th percentile
Overweight
85th percentile to less
than 95th percentile
Obese
≥ 95th percentile

Table 3. BMI in Adults
Individuals ≥20 years of age
Weight Status
BMI
Category
Underweight
< 18.5
Healthy weight
18.5-24.9
Overweight
25.0-29.9
Obese
30.0 and above

Part II- Parent Questionnaire

The data obtained from the non-validated portion of the questionnaire was entered
into an Excel database and descriptive statistics were performed for the following:
participant demographics (parents of children with SMS), affected child’s medical, social,
exercise and diet history.

Hyperphagia Questionnaire

The hyperphagia questionnaire used in Part II of the study was scored according to
the validated parameters. As the HQ is scored on a Likert scale, mean scores were calculated
for each question in the HQ. Individuals were also given a mean score for the three factors
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present in the HQ: hyperphagic behavior, hyperphagic drive and hyperphagic severity. The
mean scores for the three factors were compared using the following variables: age, gender
and BMI. Two sample t-tests were calculated to assess for differences between the mean
HQ scores between individuals who were healthy weight and obese weight, overweight and
obese, healthy weight and overweight, obese and non-obese. An ANOVA was performed to
assess for differences in the mean behavior, drive and severity scores between all BMI
classifications. Two sample t-tests were performed to assess for differences in mean
behavior, drive and severity scores between males and females. Individuals were also
categorized by age group and an ANOVA was performed to assess for differences in mean
scores according to age group. Comparisons were made between responses from the nonvalidated portions of the questionnaire to responses from the validated portion of the
questionnaire.

Fisher’s exact test allowed for the examination of the relationship between reported
amount of food eaten and BMI classification and the relationship between reported
increased interest in food and BMI classification.

As the true prevalence of hyperphagia in individuals with SMS is currently unknown
there were no definitive guidelines as to what defines hyperphagia in the SMS population.
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RESULTS
Part I-Characterization of Growth Patterns
In order to characterize the growth (height, weight and BMI) of a cohort of individuals
with Smith-Magenis syndrome, a retrospective chart review was conducted. In addition to the data

collected using the retrospective chart review, the data presented in Part I also includes the
height, weight and corresponding BMI measurements of 25 individuals with SMS whose
parent’s recorded their child’s height and weight on the parent questionnaire.
When the data obtained from the chart review and questionnaire was combined, at
least one set of growth measurements (both height and weight ascertained at the same time)
was available for all 78 individuals with SMS. Of the 78 total individuals, 35 were male
(45%) and 43 were female (55%). The number of growth measurements available for each
individual varied from one to six sets of measurements. The majority of individuals, 51
(61.5%), had only one or two growth measurements available. Figure 1 provides a graphical
representation of available growth measurements.
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Figure 1. Growth Measurements
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A total of 194 weight measurements were analyzed of which, 169 were obtained
from the chart review and 25 were obtained from the questionnaire. A total of 167 height
measurements were analyzed, of which, 142 were obtained from the chart review and 25
were obtained from the questionnaire. There were 167 sets of measurements that included
both weight and height measurements.
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Age
The mean and median age was calculated using the individual’s age at the last
recorded measurement. The mean age at the final measurement was 13.7 years and the
median age was 11.1 years for all 78 individuals. The youngest age recorded was a birth
measurement (age=0) and the oldest age recorded was 51 years. Based on their age at their
last recorded measurement, individuals were coded into age groups using the classifications
provided by the CDC. Table 4 provides a detailed overview of the age distribution in our
SMS cohort.

Table. 4 Age Distribution, Overall Population
n=78
# of
Age Group Corresponding Age
%
individuals
1
0-23 months
4
5%
2
2-5 years
16
21%
3
6-11 years
22
28%
4
12-19 years
22
28%
5
>20years
14
18%
Total
78
100%

Growth Measurements
The mean height and weight were calculated for the combined cohort, as well as
separately for males and females after stratification by age group. Table 5 summarizes the
mean height and weight for the combined cohort. The mean age for each age group is also
provided.
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Table 5. Growth Measurements, Combined Males & Females

Age
Group

Age

1
2
3
4
5
Total

0 -23 m
24 m - 5yrs
6 - 11 yrs
12- 19 yrs
> 20 yrs

Mean height (cm)
SD
µ

Mean Age
(years)

n

0.34
4.09
8.60
15.79
30.88

24
50
42
32
19
167

61.5
94.4
120.99
151.78
162.21

13.3
9.09
14.09
11.14
11.17

Mean weight (kg)
n
SD
µ

49
51
42
33
19
194

4.93
15.25
28.47
60.75
73.73

2.76
3.65
15.06
20.77
15.22

Both weight and its corresponding height measurement were obtained for 96 females
in the cohort. There were 19 females who had weight measurements but were missing the
corresponding height measurement. Table 6 summarizes the mean height and weight for the
females in the cohort. The mean age for each age group and the number of measurements
are also provided.

Age
Group
1
2
3
4
5
Total

Age
0 -23 m
24 m - 5yrs
6 - 11 yrs
12- 19 yrs
> 20 yrs

Table 6. Growth Measurements, Females
Total Number of Female Growth Measurements
Mean height (cm)
Mean weight (kg)
Mean Age
n
n
SD
n
SD
µ
µ
(years)
24
28
27
19
7
105

0.36
4.12
8.59
15.99
32.3

15
28
27
19
7
96

58.8
92.94
119.34
148.93
153.14

12.05
8.91
12.77
10.92
7.17

24
28
27
19
7
105

4.9
14.9
25.9
57.9
68.8

2.8
3.84
12.1
21.07
14.67
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Both height and weight measurements were obtained at the same time for 71 males
in the cohort. There were 18 males who had a weight measurement but they were missing
the corresponding height measurement. Table 7 summarizes the mean height and weight for
males in the cohort. The mean age for each age group is also provided.

Age
Group

Age

1
2
3
4
5
Total

0 -23 m
24 m - 5yrs
6 - 11 yrs
12- 19 yrs
> 20 yrs

Table 7. Growth Measurements, Males
Total Number of Male Growth Measurements
Mean height (cm)
Mean weight (kg)
n
Mean Age
n
SD
n
SD
µ
µ
(years)
25
23
15
14
12
89

0.33
4.06
8.63
15.5
30.1

9
22
15
13
12
71

66.01
96.25
123.98
155.93
167.5

14.05
9.18
16.24
10.5
9.66

25
23
15
14
12
89

4.95
15.68
33.0
64.58
76.13

2.79
3.43
18.89
20.47
15.5

Body Mass Index (BMI)
Body Mass Index (BMI) was calculated for all individuals greater than 24 months of
age. There were four individuals who were less than 24 months of age at their last recorded
measurement; therefore BMI could not be calculated for these individuals. For individuals
less than 20 years of age, BMI and BMI percentile for age were calculated. The
interpretation of BMI during childhood and adolescence is different than the interpretation
of BMI in adulthood, thus it was necessary to calculate BMI percentile in order to interpret
the BMI of individuals less than 20 years of age. For individuals greater than 20 years of
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age, BMI was calculated and interpret
interpreted
ed using the CDC’s recommendation for the
interpretation of BMI in adults (Statistics, N.C.f.H., 2000.).
Figure 2 provides a graphical representation of BMI distribution of SMS individuals
at the last recorded measurement for 74 individuals.

Figure. 2 BMI at Last Recorded
Measurement, n=74
Underweight
n= 6
8%
Overweight
n=15
20%

Healthy weight
n= 33
45%
Obese
n= 20
27%

* BMI could not be calculated on 4 individuals < 24 months
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Weight-for-age, Height-for-age and BMI-for-age Z-score calculations
In order to interpret the meaning of the height, weight and BMI values of individuals
with SMS, height-for-age, weight-for-age and BMI-for-age Z-scores were calculated. The
z-score is defined as: “the deviation of a given variable, x, from the mean divided by the
standard deviation” (Dawson & Trapp, 2004,2001) and it indicates how different a raw
value is from a population mean. A negative z-score corresponds to a value less than the
population mean and a positive z-score corresponds to a z-score greater than the mean. For
our analysis the population mean and standard deviation used in the calculation were based
on the normally distributed reference standard as defined by the CDC (Statistics, N.C.f.H.,
2000). Therefore, the calculation of z-scores is able to provide information on how the

growth parameters of individuals with SMS compare to that of the general US population.
For males and females age 24 months – 19 years of age the height-for-age, weightfor age and BMI-for-age Z scores were calculated using the reference standard values
corresponding to their given age and gender. For males and females >20 years of age their
height-for-age, weight-for age and BMI-for-age Z-scores were calculated using the reference
standard for a 19-year-old of their given gender.
One sample t-tests were run using the calculated Z-scores for the following: heightfor-age, weight-for-age and BMI-for-age. Table 8 provides detailed information regarding
the mean Z-scores for males and Table 9 provides detailed information regarding the mean
Z-scores for females, reported by age category.
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Males-height-for age Z-scores
For males in all age categories, the difference in height-for-age mean Z-scores
between males at the previously described age groups and what is expected for their age was
statistically significant (p = 0.01, <0.001, 0.03, 0.02 and 0.0065, respectively) demonstrating
the male SMS individuals in all age categories in this cohort are shorter than the reference
age-specific standards for the general population. Table 8 provides detailed information
regarding the height-for-age Z-scores for males.
Males-weight-for age Z-scores
For males in all age categories, the weight-for-age Z score p-values were not
statistically significant demonstrating the weight of males in our SMS cohort did not differ
(either higher/larger or lower/smaller) from what is expected in the general population based
on age (p= 0.12, 0.10, 0.68, 0.22 and 0.35 respectively.)
Males-BMI-for age Z-scores
For all males in all age categories, the calculated mean BMI-for-age Z-scores were
positive, demonstrating that the mean-BMI-for-age was greater than the 50th percentile. At
age groups 6-11years, 12-19 years and > 20 years, the difference in BMI-for-age mean Zscores between males of these age groups and what is expected in the similar age-specific
general population was statistically significant (p=0.023, 0.0023 and 0.0018, respectively)
demonstrating that the male SMS individuals in this cohort have a higher BMI than what is
expected for their age.
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Females-height-for age Z-scores
For females of all age groups, all of the mean z-scores for height were negative
which correspond to raw values below the age-specific 50th percentile. This difference in
height-for-age mean Z-scores and what is expected for their age was statistically significant
(p= 0.0016, <0.001, < 0.001, 0.001 and 0.009, respectively) demonstrating the female SMS
individuals in this cohort in all age groups are significantly shorter than expected based on
their age.
Females-weight-for age Z-scores
The calculated weight-for-age mean z-scores were negative for females 0-23
months, 24 months- 5 years and 6-11 years. These negative z-score for females correspond
to values less than the 50th percentile. The difference in mean-weight-for-age Z-scores and
what is expected based on their age was statistically significant (p= 0.0035, 0.0122 and
0.008, respectively.), demonstrating the female SMS individuals in this cohort from the ages
of 0-23 months, 24 months -5 years and 6-11 years, weigh less than what is expected for
their age. It is only in the age category of 12-19 years and ≥ 20 years that the mean weightfor-age Z-scores are positive. In other words, prior to age 12, female SMS individuals in
this cohort had weight-for-age mean z-scores less than the 50th percentile and at age 12 years
and older, female individuals with SMS in this cohort had weight-for-age mean z-score
greater than the 50th percentile. Although the weight-for-age mean z-scores for females
crossed from less than the 50th percentile to greater than the 50th percentile as they aged,
statistical significance was not achieved (p= 0.50 at 12-19 years and p= 0.192 at ≥20 years.)
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Females BMI-for-age Z-score
For females of all age groups, the calculated mean BMI-for-age Z-scores are
positive, thus corresponding to BMI’s greater than the 50th percentile. In the following age
groups: 24 months -5 years, 12- 19 yrs and > 20 years, the difference in BMI for age mean
Z-scores and what is expected for their age was statistically significant (p= <0.001, 0.013
and 0.0039, respectively) demonstrating that the female SMS individuals in these age groups
have higher BMI than what is expected for their age.
In summary, it appears that both males and females with SMS are shorter than their
peers, but have average weight, thus corresponding to higher BMI’s. Figures 3-5 provide a
graphical representation of the mean height-for-age, weight-for age and BMI-for-age Zscores for males and Figures 6-8 provide a graphical representation of the mean height-forage, weight-for-age and BMI-for-age Z-scores for females.
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0 -23 m
24 m - 5 yrs
6 - 11 yrs
12- 19 yrs
> 20 yrs
Total

0 -23 m
24 m - 5 yrs
6 - 11 yrs
12- 19 yrs
> 20 yrs
Total

N
9
22
15
13
12
69

Table 8. Z-score for Males, by age group
Z score height
Z score weight
SD
p
n
SD
µ
µ
-1.19
1.08
25
-0.33
1.03
0.01
-1.43
1.49
23
-0.52
1.45
< 0.001
-1.31
2.11
15
0.288
2.65
0.0304
-1.50
1.39
14
0.575
1.67
0.0022
-1.40
1.43
12
0.351
1.25
0.0065
89

n
15
28
27
19
7
96

Table 9. Z-score for Females, by age group
Z score height
Z score weight
SD
p
n
SD
p
µ
µ
-1.46
1.45
24
-0.813
1.223 0.0035
0.0016
-2.13
1.05
28
-0.719
1.42
0.0122
<0.001
-1.99
1.12
27
-0.842
1.51
<0.001
0.008
-1.89
1.51
19
0.294
1.884 0.5041
<0.001
-1.65
1.17
7
0.717
1.29
0.192
0.009
105

p
0.12
0.10
0.68
0.22
0.35

n
22
15
13
12
62

n
28
27
19
7
89

Z score BMI
SD
µ
0.59
1.63
1.45
1.10

1.48
2.47
1.36
0.93

Z score BMI
SD
µ
1.09
0.43
1.29
1.84

1.19
1.52
2.04
1.07

p
0.074
0.023
0.0023
0.0018

p
<0.001
0.16
0.013
0.0039
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Figure 4, Two way scatter plot, Males, weight-for-age
Z-scores by age group
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Figure 3, Two way scatter plot, Males, height-for-age
Z-scores by age group
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Figure 6. Two way scatter plot, Females, height-for-age
Z-scores by age group
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Figure 7. Two way scatter plot, Females, weight-for-age
Z-scores by age group
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Figure 8. Two way scatter plot, Females, weight-for-age
Z-scores by age group
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Part 2- Parent Questionnaire
Part II of this study involved the use of a parent questionnaire to assess hyperphagia
or related abnormal food behaviors in individuals with SMS. The parent questionnaire was
used to provide information on the food related behaviors that may be related to overweight
and obesity among individuals with SMS.
Demographics
A total of 25 questionnaires were completed by parents of children and adults with
Smith-Magenis syndrome. All of the participants who completed the questionnaire were
ascertained through a database of SMS patients maintained by Baylor College of Medicine
(BCM) at Texas Children’s Hospital. Twenty-five completed questionnaires were received
out of the 89 total questionnaires mailed, corresponding to a response rate of 28.1%.
Demographic information was available for 24 of 25 questionnaires as one individual did
not complete the demographic portion of the questionnaire. Not all participants answered all
questions within the demographic portion of the questionnaire.
Twenty out of twenty five participants correctly reported their age on the
questionnaire. There was one individual who did not respond to any question on the
demographic section of the questionnaire, and four individuals who listed their child’s age
and not their own age. Of the twenty participants who correctly indicated their age on the
questionnaire, the average age of the participants was 50.3 years with a range of 34 years to
75 years. The majority of the participants were Caucasian (n=19; 79.17%) with English
being the primary language (n=21; 87.50%). Other languages included Spanish (n=2;
8.33%) and Chinese (n=1; 4.17%). The majority of participants reported they were married
or living as married (n=21; 87.5%). One participant (4.17%) indicated they were separated
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and two individuals (8.33%) indicated they were divorced. None of the participants
identified themselves as single. The majority of participants (n=13; 54.16%) indicated they
had a Bachelor’s degree or an advanced education degree. The lowest level of education was
9th to 11th grade in one individual (4.17%). Seventy nine percent (n=19) of the
questionnaires were filled out by mothers, with fathers completing 16.67% (n=4). One
questionnaire was completed by an adoptive parent. The majority of participants (n=15;
62.5%) were employed. The average yearly income ranged from less than $25,000 (n=1;
4.35%) to greater than $100,000 (n=10; 43.48%). There were two individuals who preferred
not to provide their average income and either indicated “prefer not to answer” or left the
question blank. Table 10 provides detailed information on the demographics of the
participants (parents/caregivers).
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Table 10. Demographics of Participants(Parents)
Completed Questionnaire
Number

Total Participants
(N)

25

Number

%

28.1%

Marital Status
Married/Living as married

Age
34-44

6

30%

45-54

9

45%

55+

5

25%

20
White
Hispanic
Asian

21

87.5%

Separated

1

4.17%

Divorced

2

8.33%

24
Employment Status
Yes, Employed
No, Not Employed

Ethnicity

62.5%

9

37.5%

79.2%
16.7%

Annual Income

1

4.17%

Less than $25,000

1

4.2 %

$25-50,999

6

25%

$21-74,999

2

8.15%

3

12.5%

10

42%

2

8.15%

Primary Language

24

English

21

87.5%

$75-99,999

Spanish

2

8.33%

$100,000 or more

Other (Chinese)

1

4.17%

Prefer not to answer/left
blank

24

24

Other (adoptive
mother)

15

19
4

24

Relationship to child
with SMS
Mother
Father

%

Highest Education Level
19
4
1

24

79.2%
16.7%
4.2%

9th to 11th grade
High School or GED
Some college
Associates Degree
Bachelor’s Degree
Advanced Degree

1
3
6

4.17%
12.5%
25.0%

1
5
8
24

4.17%
20.8%
33.3%
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Demographics of SMS individuals
Demographic information was available for 25 individuals with SMS. Nine individuals
(36%) were male and 16 individuals (64%) were female. The median age of individuals with SMS in
this study was 20 years with a range of 8 years of age to 51 years of age. Thirteen individuals (52%)
were greater than 20 years of age. Individuals were categorized by age using the classifications
provided by the CDC. Table 11 provides information on the age distribution of SMS individuals.

Table 11. Age Distribution of SMS individuals
Age Group

Corresponding Age

#

%

1
2
3
4
5

0-23 months
2-5 years
6-11 years
12-19 years
>20years

0
0
3
9
13
25

0
0
12%
36%
52%
100%

Child’s Medical History
The average age at diagnosis was 8.65 years of age with a range of 1 month of age to
30 years of age, with most individuals (n=12; 48%) diagnosed prior to five years of age.
The majority of parent’s (n=17; 68%) reported their child was diagnosed by a geneticist and
most had a 17p11.2 deletion (n=22; 88%). One parent reported their child had a RAI1
mutation, while two parents reported they were unsure of the genetic etiology of SMS in
their child. Seven out of twenty four parents (28%) reported their child had been diagnosed
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with failure to thrive (FTT). Two parents (8%) reported their child needed a feeding tube;
neither reporting surgical placement of the feeding tube.
Regarding congenital anomalies, the most common congenital anomaly reported by
parents was heart defect; eight parents (32%) reported their child had been diagnosed with a
heart defect. One parent reported their child was diagnosed with a cleft lip (4%), four
parents reported their child was diagnosed with a cleft palate (16%), two parents reported
their child was diagnosed with a kidney defect (8%), four parents reported their child was
diagnosed with a urinary tract defect (16%) and five parents reported their child was
diagnosed with low thyroid function (20%). Table 12 provides a detailed overview of the
medical history data as reported by parents completing the questionnaire.
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Age Diagnosed
Birth- 5 years
6-10 years
11-20 years
21+ years

Table. 12 Medical History of SMS Individuals
(as reported by parent on questionnaire)
#
%
Diagnosed Cleft Lip
Yes
12 48%
No
6 24%

Diagnosis Made By
Pediatrician
Geneticist
Neurologist
Developmental Specialist
Other

4 16%
3 12%

1 4%
17 68%
1 4%
4 16%
2 8%

Genetic Etiology
17p11.2 deletion
RAI1 mutation
Don’t know
Diagnosis of Failure to Thrive
(FTT)
Yes
No
Don’t know
Feeding Tube Placed
Yes
No

22 88%
1 4%
2

8%

#

%

1 4%
24 96%

Diagnosed Cleft Palate
Yes
No

4 16%
21 84%

Diagnosed Heart Defect
Yes
No

8 32%
17 68%

Diagnosed Kidney Defect
Yes
No

2 8%
23 92%

Diagnosed Urinary Tract
Defect
Yes
No

4 16%
21 84%

17 68%
7 28%
1 4%

Diagnosed Low Thyroid
Function
Yes
No

5 20%
20 80%

2 8%
23 92%
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Child’s Medication History
Parents were asked if their children had ever taken medication for any of the
following: heart defects, seizures, diabetes, high cholesterol, high blood pressure, thyroid
problems, kidney problems, acid reflux, kidney reflux, anxiety, depression,
hyperactivity/ADD, sleep disturbances, self-injurious behavior, aggression or obsessive
compulsive behaviors. Twenty respondents, (83.33%), reported their child had been
prescribed medication for sleep disturbances. Sixteen parents (69%) reported their children
had been prescribed medication for anxiety and fourteen, (58.33%) reported their children
had been prescribed medication for hyperactivity/ADD. Table 13 provides a detailed
overview of the medication history reported by the participants regarding their children with
SMS.
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Table 13. Medication History of Individuals with SMS as Reported by Participating Parent
Number
Heart Defect
Yes
No
Seizures
Yes
No

%

Number

%

1
21

Acid Reflux
4.55% Yes
95.45% No

8
15

65.22%
34.78%

5
18

Anxiety
21.74% Yes
21.74% No

16
7

69.57%
30.43%

3
19

Depression
13.64% Yes
86.36% No

6
17

26.09%
73.91%

High Cholesterol
Yes
No

4
18

Hyperactivity/ADD
18.18% Yes
81.82% No

14
10

58.33%
41.67%

High Blood Pressure
Yes
No

1
21

Sleep Disturbances
4.55% Yes
95.45% No

20
4

83.33%
16.67%

Abnormal Thyroid
Yes
No

4
18

Self Injurious Behavior
18.18% Yes
81.82% No

11
11

50%
50%

Abnormal Kidney
Function
Yes
No

1
21

Obsessive Compulsive
Behaviors
4.55% Yes
95.45% No

11
11

50%
50

Kidney Reflux
Yes
No

2
20

11
12

47.83%
47.83%

Diabetes
Yes
No

Aggression
9.09% Yes
90.91 No
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Parents were also asked if any of the medications taken by their child had affected
their appetite, weight or activity level. Nine parents listed at one least medication; however
only seven parents indicated the name of the medication as well as effect of the drug.
Among the nine parents who reported any medication use in their child, the most commonly
reported medication was Risperdal (n=5). Of interest is that the most commonly used drug
(Risperdal), as well as other drugs (Thorazine, Serequel, Fluoxamine), were reported to
result in increased weight and/or increased appetite. Table 14 summarizes the limited
information obtained regarding medication history and effect of appetite, weight or activity
level.

Rx Name
Risperdal

#
5

Topamax
Ritalin

1
3

Thorazine

1

Serequel
Fluoxamine
Adderall
Abilify
Inprimine

1
1
1
1
1

Table 14. Medications Prescribed
Possible Effects
INCREASED(NOTHING SPECIFIED); INCREASE
WEIGHT;INCREASE WEIGHT, INCREASE APPETITE
DECREASE (NOTHING SPECIFIED); DECREASE WEIGHT,
DECREASE APPETITE, INCREASE PHYSICAL ACTIVITY
INCREASE WEIGHT, INCREASE APPETIE, DECREASE
PHYSICAL ACTIVITY
INCREASE WEIGHT, INCREASE APPETITE
INCREASE WEIGHT, INCREASE APPETITE

To further investigate if a medication may have caused a change in behavior or
weight in a child, the corresponding BMI of the child was examined. Of those who reported
that a medication increased their child’s weight or appetite levels (n= 6), one individual had
a BMI in the healthy range, 2 had an overweight BMI and three had an obese BMI. Of those
who listed a medication but did not report the effect (n=2), both individuals had a healthy
BMI. Of those individuals who did not respond to the question, eight were classified as
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healthy BMI, four were classified as overweight BMI and four were classified as obese
BMI. One parent reported a medication (Ritalin) decreased her child’s weight; this
individual had an obese BMI.
Family History Information
To assess for additional factors that could affect a child’s weight, and in turn BMI
and overall health status, parents were asked whether or not there was a family history of
any of the following: overweight, obesity, hypertension, diabetes, pre-diabetes, high
cholesterol and heart disease. Table 15 provides family history information.
Table 15. Family History
Number
Overweight
Yes
9
Missing
16

36%
64%

Obesity
Yes
Missing

7
18

28%
72%

Hypertension
Yes
Missing

11
14

44%
56%

Diabetes
Yes
Missing

10
15

40%
60%

Pre-Diabetes
Yes
Missing

5
20

20%
80%

High-Cholesterol
Yes
Missing

12
13

48%
52%

Heart Disease
Yes
Missing

5
20

20%
80%

%
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Child’s Social and Education History
Sixteen out of twenty-four (66.67%) of parent’s indicated their children lived at home, with
seven (29.17%) parents indicating their child lived in a group home/assisted living facility. One
parent (4.16%) indicated her child lived in her own home with 24-hour support staff.
Parents were also asked “what was the highest level of schooling your child has completed?”
Figure 9 summarizes the responses regarding the child’s education.

High SchoolSpecial
Diploma
2
8%

Figure 9. Distribution of education
in SMS individuals
N=25

Currenly in
High School
1
4%

High SchoolNot Specified
11
44%

Did not attend
school
1
4%
No
Response
2
8%

Middle School
4
16%

Currently in
Elementary
School
3
12%
Did not finish
Elementary
School
1
4%
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Child’s Exercise History
Twelve parents, 48%, reported their child had a regular exercise program. Of those parent’s
who reported their child was able to exercise but that their child did not have a routine, the most
common response provided as to why those children did not exercise was “will not participate in
physical activity.”
Dietary History
On the questionnaire that was created for use this study, there were ten questions targeted to
assess the dietary history of SMS individuals. Parents were asked if they felt their child had daily
eating patterns similar to other children his or her age. Fifteen parents answered Yes (60%) and 10
parents answered No (40%). All parents (N=25; 100%) indicated their children ate breakfast, lunch,
dinner and snacks each day. Fifty-two percent of parents (n=13) indicated their child snacked prior
to bed time.
Parents were asked to list their child’s top three favorite snacks. Because of the variable
responses provided, categorizations of snacks were created for better analysis. After all of the
questionnaires were received, the responses to this question were looked at as a whole and
categorizations were created for the snack items listed. The snack categories were: “healthy”, which
included items such as fruits and vegetables; “non-healthy”, which included items such as cookies,
chips and cakes and a third “other” category which included foods such as pretzels, popcorn and
pudding. Based on these snack classifications, 18 out of 25 parents (72%) indicated their child’s
favorite snack was an item classified under the “non-healthy” item, 2 out 25 (8%) indicated their
child’s favorite snack was in the “other” category and 5 out of 25 parents indicated their child’s
favorite snack was an item classified as “healthy.”
Parents were also asked to categorize the amount of food their child ate. Six parents (25%)
indicated they felt their child ate less than normal amounts of food, eight parents (33.33%) indicated
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they felt their child ate normal amounts of food and ten parents (41.67%) indicated they felt their
child ate greater than normal amounts of food. Parents were asked if their child binge ate; 50%
indicated Yes and 50% indicated No.
As individuals with SMS have disruptive sleep patterns, it was important to assess the
presence of this finding within our questionnaire as well as to investigate whether individuals with
SMS were also participating in night-time food seeking which may be considered an abnormal food
seeking behavior. The majority of parents (n=12;48%) indicated their child woke up 2-3 times per
night, with 13.64% (n=3) of parent’s indicating their child woke up greater than or equal to four
times each night.
Parents also reported, of the times their child woke per night, how often they ate. Twelve
parents (48%) indicated never, two (8%) indicated rarely, three (12%) indicated occasionally and
five (20%) indicated always (Figure 10). Three parents hand wrote on their questionnaire that their
child does not participate in night-time food seeking because the food is now locked. This response
was interpreted to mean night-time food seeking is currently not a problem for these three SMS
individuals because the food is now locked and they are unable to access it. A separate category was
created for those individuals(12%) who indicated their child no longer participated in night-time
food seeking, as the food is now locked.
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Figure 10. Distribution of children
participating in night-time food seeking
Food Locked
n= 3
12%
Always
n= 5
20%

Never
n= 12
48%

Occasionally

n=3
12%

Rarely
n=2
8%

The majority of parents, (nineteen; 76%) indicated they have to lock food away from their
child. Of those six parents who indicated they did not lock food from their child, one parent reported
they try not to have tempting food in the house, but they don’t lock the food.

Growth Measurements of individuals with SMS as reported by their Parents
In order to obtain the most recent growth parameters for the SMS individuals whose parents
completed the mail out questionnaire, parents were asked to provide their child’s current height and
weight. Growth parameters were reported by parents in all 25 responses. The average height for the
cohort was 153.6 cm and the average weight was 65.2 kg. For males, (n=9) the average height was
167.67 cm, the average weight was 73.9 kg and the average BMI was 26.2. For females, (n=16) the
average height was 145.71 cm the average weight was 60.4 kg and the average BMI was 27.73.
Tables 16-18 provide an overview of growth parameters in the cohort.
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N
25

µ
153.6

Height (cm)
SD
Min
18.64 91.4

Table 16. Growth Measurements, All individuals,
N=25
Weight (kg)
Max
SD
Min
Max
µ
µ
183
65.2
20.32
23
100
27.17

Height (cm)
SD
Min

Table 17. Growth Measurements, Males
n=9
Weight (kg)
Max
SD
Min
Max
µ

6-11yrs
12-19yrs
> 20yrs

n
0
1
8

163
168.13

---9.46

---155

---183

55
76.2

---14.62

---60

Total

9

167.6

9.011

155

183

73.9

15.4
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µ

6-11yrs
12-19yrs
> 20yrs

n
3
8
5

µ
115.5
152.9
152.4

Height (cm)
SD
Min
21.13
91.4
8.76
135
5.77
145

Total

16

145.71

18.15

91.4

SD
5.55

BMI
Min
16.89

Max
38.95

BMI
µ

SD

Min

Max

---100

20.7
26.8

---3.52

---22.6

---30.78

100

26.2

3.88

20.7

30.78

Table 18. Growth Measurements, Females
n=16
Weight (kg)
Max
SD
Min
Max
µ
131
28.3
5.03
23
33
163
67.6
19.14
39
90
160
68
11.78
52
79

µ
21.82
28.9
29.3

SD
5.1
6.9
4.8

Min
16.9
21.4
24.2

Max
27.1
38.9
35.1

163

27.73

6.35

16.9

39

60.4

21.55

23

90

BMI
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BMI and BMI percentile in individuals < 20 years
For individuals less than 20 years of age BMI and BMI percentile were calculated. BMI
percentile provides information regarding a given child’s BMI in comparison to that of other
children his or her own age and gender. There were eleven females and one male less than 20 years
of age, to give a total of twelve individuals for which the BMI percent was calculated. As there was
only one male, limited statistically analysis could be performed regarding BMI in males less than 20
years of age. For females less than 20 years of age, the average BMI was 27.04 and the average BMI
percent was 78.1, which is considered “healthy”. Table 19 provides detailed information on the BMI
of individuals less than 20 years of age.
Table 19. BMI and BMI% in individuals < 20 years of age
n=12
BMI
BMI percentile
n
n
SD
Min
Max
SD
Min
µ
µ

Max

Males
Females

1
11

20.7
27.04

7.03

16.9

39

1
11

29
78.1

25.6

23.1

98

All

12

26.5

6.9

16.9

39

12

74.0

28.2

23.1

98

Figure 11 illustrates the distribution of BMI classifications in individuals less than 20 years
of age, based off BMI%.

Figure 11. BMI, Individuals < 20 years of age,
n=12
Obese
n= 5
42%

Overweight
n= 1
8%

Healthy
weight
n= 6
50%

Weight Category
Underweight
Healthy weight
Overweight
Obese

BMI %
BMI <5th
th
5 ≤ BMI <85th
85th ≤ BMI <
95th
BMI ≥95th
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BMI in individuals ≥ 20 years
There were 13 individuals greater than 20 years of age, for which BMI was calculated and
interpreted using the CDC’s recommendation for the interpretation of BMI in adults. The average
BMI for individuals > 20 years of age was 27.8. Based on these classifications, 5 individuals
(38.46%) were classified as healthy weight, 5 individuals (38.46%) were classified as overweight
and 3 individuals (23.08%) were classified as obese, corresponding to 61.54% of all individuals
greater than
han 20 years of age being either overweight or obese. There were no individuals classified
as underweight. Figure 12 illustrates the BMI classifications in individuals greater than 20 years of
age.

Figure 12. BMI, Individuals ≥ 20 years of age
Obese
n= 3
23%

Healthy weight
n= 5
39%

Overweight
n= 5
38%

Calculation of BMI% in individuals < 20 years of age and BMI in individuals greater than
20 years of age allowed for the examination of BMI in all individuals combined. When analyzing
BMI classifications for all individuals (N=25), 11 (44%) were classified as healthy weight, 6 (24%)
were classified
fied as overweight and 8 (32%) were classified as obese. Thus 56% of individuals in the
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combined cohort have an overweight or obese BMI. There were no individuals classified as
underweight. Figure 13 provides an illustration of BMI classifications in all individuals.

Figure 13. BMI, All Individuals,
N=25

Obese
n=8
32%
Healthy weight
n=11
44%
Overweight
n=6
24%

Z-scores
It was necessary to calculate the Z-score for height-for-age, weight-for-age and BMI-for-age
to allow for comparison between the reference standard as defined by the CDC and the SMS cohorts.
One sample t-tests were run using the calculated Z-scores for the following: height-for-age, weightfor-age and BMI-for-age. The negative mean Z-score for height (µ = -1.72) demonstrates this
cohort of SMS individuals were significantly shorter for their age (p= 0.001). The mean weight-forage Z-scores for the combined cohort, were not statistically significant (p-value = 0.062),
demonstrating the weight for age Z-scores in the SMS individuals were not statistically different
(either higher/larger or lower/smaller) from age matched standardized controls in the general
population. Despite non-significant weight-for-age mean Z-scores, the positive mean Z-score for
BMI for age (µ = 1.59) demonstrates the SMS individuals have significantly higher BMI’s for age (p
<0.001). Table 20 provides detailed information regarding the mean Z-scores for all individuals for
height, weight and BMI.
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µ
-1.72

Table 20. Z-scores for All individuals
N=25
Z score height
Z score weight
SD
p
µ
SD
p
1.8
0.0001
0.513
1.3
0.062

Z score BMI
µ
SD
p
1.59
1.24
<0.001

Z-score comparisons by Gender
The height-for-age Z scores, weight-for-age Z scores BMI-for-age Z-scores were examined
separately for males and females. One sample t-tests were also run separately for males and females
and by age groups to assess for differences within these categories. For males, (n=9), their heightfor-age Z score and weight-for-age Z score were not statistically significant demonstrating the height
and weight in the male SMS cohort did not differ (either higher/larger or lower/smaller) from what is
expected for their age (p=0.052 and p=0.21 respectively). However, the difference in BMI for age
mean Z-scores between SMS males and age appropriate controls was statistically significant,
demonstrating male SMS individuals have higher average BMI for age. (p=0.01) Table 21 provides
a detailed overview of Z-score values in males.

Z score height
µ
-1.02

SD
1.34

p
0.052

Table 21. Z-score for Males,
n=9
Z score weight
µ
0.46

SD
1.02

p
0.21

Z score BMI
µ
1.06

SD
0.95

p
0.01

For females, n=16, their weight for age mean Z-score was not statistically significant
demonstrating the mean weight-for-age in the female SMS cohort did not differ from what is seen in
the general population (p=0.16). The mean Z-score for height (µ=
= -2.12) demonstrated the females
in our population were significantly shorter for their age (p= 0.006). The difference in BMI-for-age
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mean Z-scores between all females and what is expected for their age was statistically significant (p<
0.001) demonstrating female SMS individuals have higher BMI for age than what is expected.
Table 22 provides a detail overview of Z-score values in females.

Table 22. Z-scores for Females,
n=16
Z score weight

Z score height
SD
1.94

µ
-2.12

p
0.006

µ
0.54

SD
1.48

Z score BMI

p
0.16

µ
1.89

SD
1.31

p
< 0.001

Z-score comparisons by Age & Gender
We also examined the Z-scores for height-for-age, weight-for-age and BMI-for-age by fist
subdividing by gender and then by age. For males, the only Z-score p-value that reached statistical
significance was the BMI-for-age Z-score for males > 20 years of age, demonstrating that males >
20 years of age had larger BMI’s than what was expected for their age (p= 0.005). Table 23 provides
a detailed overview of Z-scores for males, by age group.

Table 23. Z-score for Males, by Age Group
Z score height
Z score weight
6 - 11 yrs
12- 19 yrs
> 20 yrs
Total, All
Males

n
0
1
8

µ
0
-0.15
-1.12

SD
0
1.39

p
0
0.055

µ
0
-0.407
0.57

9

-1.02

1.34

0.052

0.46

Z score BMI

SD
p
0
0
1.034 0.163

µ
0
-0.34
1.23

SD
0
0.8514

p
0
0.005

1.02

1.06

0.95

0.01

0.21

For females, n=16, there were several Z-score p-values that reached statistical significance.
For females 12-19 years of age, their height-for-age Z score and BMI-for-age Z score p-values were
both statistically significant (p= 0.007 and p=0.01 respectively), demonstrating females age 12-19
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years of age were significantly shorter and had larger BMI’s than what was expected based on their
age. For females > 20 years of age their height-for-age Z score and BMI-for-age Z score p-values
were both statistically significant (p= 0.01 and p=0.019 respectively), demonstrating females > 20
years of age were significantly shorter and had larger BMI’s than what was expected based on their
age. Table 24 provides a detailed overview of Z-scores for females, by age group.

Table 24. Z-scores for Females, by Age Group
Z score height
Z score weight
6 - 11 yrs
12- 19 yrs
> 20 yrs
Total

Z score BMI

n
3
8
5

µ
-3.6
-1.7
-1.83

SD
4.06
1.3
0.89

p
0.26
0.007
0.01

µ
-0.59
0.92
0.62

SD
1.54
1.64
1.06

p
0.58
0.16
0.26

µ
1.89
1.89
1.88

SD
2.05
1.35
1.1

p
0.251
0.0053
0.019

16

-2.12

1.94

0.006

0.54

1.48

0.16

1.89

1.31

< 0.001
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Hyperphagia Questionnaire
The HQ was scored and analyzed using the methods described by Dykens et al., 2007.
Through the use of the HQ in the PWS population, three factors, also known as subscales, emerged
that accounted for 57% of the variance within hyperphagia. These subscales were: behavior, drive
and severity. Eleven of thirteen questions on the HQ corresponded to one of these three subscales.
Question 12 and question 13 did not correspond to any of the three subscales and were therefore
considered separately. Means scores were calculated for each question in the HQ. Mean scores for
the behavior, drive and severity subscales were also calculated. Comparisons of overall scores as
well as mean scores for each subscale were made.
Questions on the HQ were scored based on a Likert scale of 1 to 5, with a score of 1= not a
problem and a score of 5= a severe and/or frequent problem. The results to the questions are
grouped by the corresponding subscale. Higher scores on the HQ indicate higher levels of
hyperphagia. The overall behavior, overall drive and overall severity scores for each individual are
the sum of the scores for each question within its given subscale. For example if everyone had
answered every question within the hyperphagic behavior subscale with a 5, indicating the highest
level of severity, the overall hyperphagic behavior score would be equal to 25 (there are five
questions within hyperphagic behavior; 5 questions multiplied by a score of 5 would give a totals
score equal to 25.) In the same respect if everyone had answered every question within the
hyperphagic behavior subscale with a 1 indicating the lowest level of hyperphagic severity, the mean
hyperphagic behavior scale would be equal to 5. These overall subscale scores for all individuals
were used to calculate the mean subscale score for our cohort. Table 25 provides the mean scores for
all 25 individuals who completed the HQ.
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Table 25. Hyperphagia Questionnaire Results, Mean Scores,
All Individuals, N=25
Question #
N*
Mean
SD
Min
Max
Score
Behavior
10
2
8
5
4
Mean Behavior

25
23
22
23
25
20

3.08
2.52
2.45
2.48
1.28
11.45

1.32
1.5
1.5
1.7
0.74
4.96

1
1
1
1
1
5

5
5
5
5
4
22

25
25
25
24
24

3.04
2.8
3.12
2.38
11.3

1.17
1.04
1.09
1.05
3.71

1
1
1
1
4

5
5
5
5
20

Drive
1
3
6
9
Mean Drive

Severity
7
24
2.54 1.32
1
5
0.68
1
4
25
11
1.96
Mean Severity
24
4.54 1.77
2
9
* At least one question was left unanswered within the behavior, drive and
severity subscales by 5, 1 and 1 individuals, respectively. Scores from these
individuals were not used in the subscale mean score calculations.

Item 12 on the HQ asked: “at what age did you child first show an increased interest
in food?” 18 out of 25 parents (72%) reported their child did have an increased interest in
food. Of those 18 parents who reported their child had an increased interest in food, the
mean age of onset was 8.22 years.
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Comparison of HQ Scores by BMI
We also looked at the overall hyperphagia mean scores within the different BMI
classifications. Table 26 summarizes the overall hyperphagia mean scores for each question on the
HQ across the different BMI classifications; normal weight, overweight and obese weight. The
results are grouped by factor and items 12 and 13 were the questions that did not load onto any factor
and are therefore considered separately from the other three factors.
Interestingly individuals with an obese BMI tended to have higher behavior and drive scores
but lower severity scores.
Table 26, Overall Mean Scores, by BMI Classification
Question #

Healthy Weight

Overweight

Behavior
10
2
8
5
4

11.56
3.36
2.8
2.6
2.5
1.36

8
2.33
2.2
1.75
1.6
1

12.63
3.25
2.38
2.63
3
1.38

Drive
1
3
6
9

11.9
3
3
3.45
2.5

8.83
2.17
2.17
2.5
2

12.38
3.75
3
3.125
2.5

Severity
7
11

5.1
2.9
3.36

3.67
1.17
2

4.5
2.75
1.75
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Obese

T-tests were performed to look for statistically significant differences between the mean HQ
scores between individuals who were healthy weight and obese weight. Although the mean behavior
and drive scores were higher in individuals with obese BMI than in individuals with healthy BMI,
none of these values reached statistical significance (p-values = 0.68 and 0.79, respectively.) Table
27 provides detailed information regarding the mean behavior, drive and severity scores in
individuals with healthy and obese weight.
Table 27. Mean Hyperphagic Behavior Drive and Severity scores,
Healthy weight vs. obese weight
Hyperphagic factors
Healthy Weight
Obese
n
Mean
SD
n
Mean
SD
Behavior
9
11.55
5.53
8
12.625
4.75
Drive
10
11.9
4.04
8
12.375
3.42
Severity
10
5.1
2.02
8
4.5
1.69

p-value
0.68
0.79
0.51

Furthermore, comparisons were made between the mean HQ scores of individuals who were
overweight and those who were obese. Although the mean behavior, drive and severity scores were
higher in individuals with obese BMI than in individuals with overweight BMI, none of these values
reached statistical significance (p-values = 0.16, 0.06, and 0.33 respectively.) However, the mean
drive scores were approaching statistical significance in obese individuals. Table 28 provides
detailed information regarding the mean behavior, drive and severity scores in overweight and obese
individuals.
Table 28. Mean Hyperphagic Behavior Drive and Severity scores,
Overweight vs. Obese weight
Hyperphagic factors
Overweight
Obese
n
Mean
SD
n
Mean
SD
Behavior
3
8
3
8
12.63
4.75
Drive
6
8.83
2.78
8
12.4
3.42
Severity
6
3.67
1.211
8
4.5
1.69
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p-value
0.16
0.06
0.33

Two sample t-tests were also calculated to look for differences between the mean HQ scores
between individuals who were healthy weight and overweight. Although the mean behavior, drive
and severity scores were higher in individuals with healthy BMI than in individuals with overweight
BMI, there were not statistically different, suggesting increasing BMI is not associated with higher
mean scores on the HQ. Table 29 provides detailed information regarding the mean behavior, drive
and severity scores in healthy and overweight individuals.
Table 29. Mean Hyperphagic Behavior Drive and Severity scores,
Healthy weight vs. Overweight
Hyperphagic factors
Healthy weight (2)
Overweight (3)
N
Mean
SD
N
Mean
SD
Behavior
9
11.55
5.53
3
8
3
Drive
10
11.9
4.04
6
8.83
2.79
Severity
10
5.1
2.02
6
3.67
1.21

p-value
0.32
0.13
0.14

Finally the data was reclassified and an analysis was also run comparing obese and nonobese individuals (the latter group including both health and overweight individuals). Although the
mean behavior, drive and severity scores were higher in individuals with an obese BMI than in
individuals with a non-obese BMI, none of these values reached statistical significance (p-values =
0.40, 0.32, and 0.94 respectively) indicating that there was no statistically significant difference
between the mean behavior, drive and severity scores between individuals who are obese and those
who are not obese. Table 30 provides detailed information regarding the mean behavior, drive and
severity scores in healthy and overweight individuals.
Table 30. Mean Hyperphagic Behavior, Drive and Severity scores,
Obese vs. non-obese
Hyperphagic factors
Obese
Non-obese
n
Mean
SD
n
Mean
SD
Behavior
8
12.63
4.75 12
10.67
5.14
Drive
8
12.38
3.42 16
10.75
3.84
Severity
8
4.5
1.69 16
4.56
1.86
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p-value
0.40
0.32
0.94

An ANOVA test was performed to assess for differences in the mean behavior, drive and
severity scores between all BMI classifications. No significant differences were detected (p-values =
0.41, 0.17 and 0.30 respectively). No association between BMI and hyperphagic subscales was
found in this data set. Table 31 provides detailed information regarding the mean behavior, drive
and severity scores in healthy and overweight individuals.
Table 31. Comparison of Mean Hyperphagic Behavior, Drive and Severity
scores, by BMI Classification
Hyperphagic factors
BMI
Classification
N
Mean
SD
p-value
Behavior
Healthy
Overweight
Obese

9
3
8
20

11.56
8
12.65

5.53
3
4.75

0.41

Healthy
Overweight
Obese

10
6
8
24

11.9
8.83
12.4

4.04
2.79
3.42

0.17

Healthy
Overweight
Obese

10
6
8
24

5.1
3.67
4.5

2.02
1.21
1.69

0.30

Drive

Severity
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Comparison by Gender
Two sample t-tests were run to assess for differences in mean behavior, drive and severity
scores between males and females. Although females had higher mean scores for all three factors,
behavior, drive and severity, only the mean severity score was statistically significant (p-value=
0.038) suggesting that females with SMS may have higher levels of hyperphagic severity. Table 31
provides detailed information regarding the mean behavior, drive and severity scores in healthy and
overweight individuals.
Table 32. Comparison of Mean Hyperphagic Behavior, Drive and Severity scores by
Gender
Hyperphagic factors
Gender
N
Mean
SD
p-value
Behavior
Male
6
10
3.9
0.407
Female 14
12.07
3.4
20
Drive
Male
8
9.5
3.38
0.095
Female 16
12.19
3.63
24
Severity
Male
8
3.5
1.20
0.038
Female 16
5.06
1.80
24
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Comparison by Age
A series of ANOVAs were used to assess for difference in mean behavior, drive and severity
scores among different age classifications of SMS individuals. Individuals were classified by age
group and ANOVAs were used to assess for differences. Although not statistically significant, the
mean behavior, drive and severity scores increased with increasing age, suggesting that there may be
a relationship between age and hyperphagic severity. The mean behavior, drive and severity score pvalues were 0.11, 0.52 and 0.71 respectively. Table 33 provides detailed information regarding the
mean behavior, drive and severity scores in healthy and overweight individuals.
Table 33. Comparison of Mean Hyperphagic Behavior, Drive and Severity scores by
Age Group
Hyperphagic factors
Age
Group
N Mean
SD
p-value
Behavior
6-11yrs
3
8
1.73
12-19yrs
9
10.2
3.83
0.11
>20yrs
8 14.13
5.82
Drive
6-11yrs
3
10
3.46
12-19yrs
9
10.5
2.79
0.52
>20yrs 12 12.16
4.39
Severity
6-11yrs
3
4
1.73
12-19yrs
9
4.33
1.802
0.71
>20yrs 12
4.83
1.85
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Comparison by Age and Gender

Due to differences between gender and age distribution within our study population
(Table 34), data for behavior, drive and severity scores were reanalyzed after adjusting age
and gender for each other. Stratification by gender showed that among females, behavior
scores were highest in the oldest age group (p=0.0018) (Table 34). In addition, among
females, although there were trends of higher scores by increasing age, there were no
statistically significant differences between the different age groups for drive (p=0.063) or
severity (p=0.115) scores. Among males, there were no statistically significant differences
in behavior (p=0.460), drive (p=0.302) or severity (p=0.200) scores between the different
age groups.
Table 34. Distribution of Gender by Age Groups

6-11yrs
12-19yrs
≥ 20 yrs
Total

Males
0
1
8
9

Females
3
8
5
16

Total
3
9
13
25

Comparison of scores for males and females was also performed after stratification
by age group. The only statistically significant difference was in the oldest age group,
where females had higher scores than males for behavior (p=0.010), drive (p=0.035) and
severity (p=0.005) (Table 35)
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Table 35. Comparison of Mean Hyperphagic Behavior, Drive and Severity scores by Age
Group and Gender

n

Males
Mean

Behavior
Drive
Severity

1
1
1

7.00
6.00
2.00

Behavior
Drive
Severity

5
7
7

10.60
10.00
3.71

6-11yrs

Behavior
Drive
Severity

12-19yrs

≥ 20 yrs

SD

4.04
3.32
1.11

n
3
3
3

Females
Mean
8.00
10.00
4.00

SD
1.73
3.46
1.73

8
8
8

10.63
11.13
4.63

3.89
2.36
1.66

3
5
5

20
15.2
6.4

1.73
4.09
1.52

Comparisons between night-time food seeking and mean hyperphagic behavior scores
Since a portion of the questionnaire used in this study was not validated, as a measure of
control, comparisons were made between validated and non-validated questions. One of the main
areas of interest was to determine if there was a correlation between night-time food seeking
(question 9 on the non-validated portion of the questionnaire) and an individual’s mean behavior
score. The mean behavior score was chosen because question 5 on the validated HQ asked “How
often does your child get up at night to food seek?” which was categorized as hyperphagic behavior.
Three parents indicated their child no longer participates in night-time food seeking behavior
as the food is now locked. Since these parents did not answer using the responses provided on the
questionnaire, it was unclear if these individual’s night time food seeking behaviors would be
classified as “never”, “rarely”, “sometimes” or “always.” Therefore, a sensitivity analysis was
performed using the following two assumptions: the behavior occurred “always” and a separate
analysis assuming the behavior occurred “rarely”.
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When analyses were performed using only those 20 individuals who answered question 9 on
the non-validated portion of the questionnaire using the responses provided and answered all other
questions assessing hyperphagic behavior, no statistically significant relationship was found
(p=0.051). However, of note, individuals in the “always” category had the highest mean behavior
scores (mean =15.75).
When analyses were performed on those individuals who answered question 9 on our
questionnaire and answered all questions which were classified under hyperphagic behavior, there
was no statistically significant difference between the mean hyperphagic behavior score and the
amount of night-time food seeking (p=0.088). Although there was no statistically significant
relationship, those four individuals classified as “always” participating in night-time food seeking
had the highest mean behavior scores (mean=15.75) and those classified as “food locked” had the
second highest mean behavior scores (mean =14.667). Figure 14 provides a graphical representation
of this data.

Figure 14 . Impact of Night-time food seeking on
Hyperphagic Behavior

Man Score

20
15
10
5
0
Food Locked Never n=9 Rarely n=2 Occasionally Always n=4
n=3
n=2
Mean Behavior Score (p= 0.088)
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When analyses were performed grouping those three individuals who reported the food was
now locked into the “always” category, a statistically significant relationship was found (p=0.04)
demonstrating increased frequency of night-time food seeking is associated with higher mean
hyperphagic behavior scores. Figure 15 provides a graphical representation of this data.

Figure 15. Impact of Night-time food seeking on
Hyperhagic Behavior
Mean Scores

20
15
10
5
0
Never n=9

Rarely n= 2

Occasionally n=2

Always n=7

Mean Behavior Score (p= 0.04)

Analyses were performed grouping those three individuals who reported the food was now
locked into the “rarely” category and no statistically significant relationship was found between
increased night-time food seeking and mean hyperphagic behavior scores (p= 0.24).
Finally, a t-test was performed between individuals who reported their child “never”
participated in night-time food seeking or “always” participated in night-time food seeking, which
demonstrated a statistically significant relationship (p=0.029), suggesting the true amount of nighttime food seeking in our SMS individuals lies somewhere in between “never” and “always.”
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Relationship between amount of food eaten and BMI
A Fisher’s exact test was performed to determine if there was a relationship between the
reported amount of food eaten by the SMS individual and their BMI classification. The p-value for
this test was, p= 0.397, demonstrating there is no statistically significant relationship between the
reported amount of food eaten and the BMI classification in our SMS population.
Relationship between increased interest in food and BMI
A Fisher’s exact test was performed to determine if there was a relationship between
increased interest in food and BMI classification. The p-value for this test was, p= 0.529,
demonstrating there is no statistically significant relationship between increased interest in food and
BMI classification in our SMS population
Relationship between hyperphagia and BMI, hyperphagia and age
Analyses were also performed comparing individuals whose parent’s reported their child had
an increased interest in food and those who parents reported their child did not have an increased
interest in food. No statistically significant relationships were found between an increased interest
in food and BMI or age group.
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DISCUSSION
Through the work of numerous researchers, the Smith Magenis Syndrome (SMS)
phenotype has been well described, including its unique and characteristic neurobehavioral
profile. Although these publications provide invaluable information regarding the phenotype
of SMS, the majority of SMS related literature is lacking detailed information regarding
height, weight and BMI. Due to the lack of detailed information available, the specific aims
of this project were to (1) characterize the growth of a cohort of individuals with SmithMagenis syndrome in order to determine the prevalence of overweight and obesity and (2)
investigate hyperphagia and related food-seeking behaviors as possible factors related to
overweight and obesity in individuals with SMS.

Growth Patterns of Individuals with SMS

Specific aim one was addressed through detailed analyses on the growth
measurements of children and adults with SMS through the use of a retrospective chart
review and growth data obtained from parental questionnaires. A minimum of one growth
measurement was available for 78 individuals with SMS. One of the initial concerns
regarding the use of a retrospective chart review involved the possibility that the majority of
the growth data obtained would be of children with SMS and would not provide information
on the growth of adolescents and adults with SMS. However, the growth data available for
review ranged from birth parameters to that of an individual 51 years of age. The wide age
range allowed for the examination of growth patterns in young children, adolescents and
adults with SMS, as well as provided information on how the growth of individuals with
SMS changes over time.
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Z-scores were helpful in comparing the growth parameters in the SMS population to
those in the general US population. For males and females in all age categories, the
difference in height-for-age mean Z-scores was statistically significant. This finding clearly
demonstrates that SMS individuals in this cohort are shorter than individuals in the general
population. Both males and females in this cohort of 78 SMS individuals had negative
height-for-age mean z-scores indicating heights less than the 50th percentile. This finding
further supports the findings in published literature regarding decreased linear growth in
individuals with SMS (Smith et al., 2004).
To further characterize the significance of height in the SMS cohort, the Z-scores
were converted into their corresponding growth percentile. At 0-24 months of age, males
were at the 10th -25th percentile and fell to the 5th- 10th percentile at age 24 month, then
remained at the 5th -10th percentile through the ≥ 20years. These percentile changes show
that although the linear growth percentile of males with SMS does fluctuate over time, after
2 years of age, the mean height for males was never greater than the 10th percentile.
The results of this study slightly contrast to the data published by Smith et al. in 2004
who found that males with SMS were at 25th percentile for height by the age of 14. In this
study, the highest height percentile reached by males occurred at the age of 0-23 months.
When the height-for-age mean z-score and corresponding percentiles for females are
examined, their decreased linear growth is even more striking than what was seen in males.
At age 0-23 months, females were at the 10th -5th percentile. However, at age 24 months-5
years, they fall to less than the 3rd percentile and remain less than the 3rd percentile through
19 years of age. By the age of ≥ 20 years, females reach the 5th -3rd percentile. As an
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individual is considered to have short stature if they are less than or equal to the 5th
percentile for age (CDC age specific growth charts, 2000), females in this cohort from the
age of ≥ 24 months have short stature.
The results of this study regarding height for age percentiles in females are similar to
those reported by Smith et al., in 2004 in that both Smith et al., and this study found females
were at the less than 3rd percentile for height by age 12 years. However, Smith et al., found
that female with SMS were between the 5th -25th percentiles for height from age 3-7 years,
whereas this study found that females age 24 months-19years were at less than the 3rd
percentile for height.
It is possible that the highest percentile for height for both males and females
occurred within 0-23 months of age because infants with SMS typically have normal growth
parameters at birth (Smith & Gropman, 2005). Although males with SMS in this cohort
were also at their highest height percentile at 0-24 months, they remained at the 10th -5th
percentile for almost all of the age ranges examined and did not fall to less than the 3rd
percentile as was seen in the females. The discrepancies in height percentile between males
and females with SMS is most likely related to the fact that in the general population, males
are taller than females and although both males and females with SMS are shorter than their
age matched peers, it would be expected that males with SMS may be taller than females
with SMS solely due to gender differences.
Both males and females with SMS had negative weight-for-age mean z-score in
early in infancy. This finding could be related to the FTT reported in individuals with SMS
at around 12 months of age (Gropman et al., 1999; Greenberg et al., 1991). At first glance,
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the changes in weight-for-age mean Z-scores for males and females with SMS are not
evident as there was no statistically significant difference between the weight-for-age Zscores. Although statistical significance was not achieved, the mean weight-for-age Z-scores
for males and females did increase with age. Interestingly, males had z-scores less than the
50th percentile until age 6-11 years and females had z-scores less than the 50th percentile
until 12 years of age. By the age of ≥ 20 years males had weight-for-age mean z-scores
equivalent to the 50-75th percentile and females had weight-for-age mean z-scores
equivalent to the 75th-95th percentile. These results confirm those published by Smith et al.,
in 2004 who reported females with SMS were at that or above the 90th percentile for weight
by the age of 12 years. However the results of this study did not correspond to those
published by Smith et al., in 2004 who reported males were at the 90th percentile for weight
by age 14.
Although the results of this study do not exactly correspond to those published by
Smith et al., in 2004, the trends in height and weight are similar. Both Smith et al., 2004 and
this study found that males and females with SMS are less than the 50th percentile for height
in all age groups where as their weight percentiles are as high as the 90th percentile by age
12 years. These changes in percentiles from early childhood to adulthood suggest that there
may be an underlying factor present in both males and females with SMS that causes their
weight to increase to greater than the 50th percentile sometime during childhood and
adolescence. This underlying factor may be related to hyperphagia as it was reported by
72% of parents surveyed in Part II of this study, who felt their child had an increased interest
in food. The majority of parents (55%) reported their child first showed an increased interest

77

in food at around 5 years of age. Additional findings related to hyperphagia in this study
will be discussed in detail later in this discussion.
For all males, the calculated mean BMI-for-age Z-scores were positive,
demonstrating the mean-BMI-for-age was greater than the 50th % percentile in all age
groups. In age groups 6-11years, 12-19 years and > 20 years, the difference in BMI for age
mean Z-scores between SMS males and the general population was statistically significant
(p=0.023, 0.0023 and 0.0018, respectively) demonstrating male SMS individuals are more
obese than what is expected for their age. Similar to weight-for-age findings, when
examining the corresponding BMI-for-age percentiles in individuals <20, an increase in
percentile over time was appreciated. At age 24 months to 5 years, males are between the
50-75th percentiles, then increase to the 90-95th percentile at age 6-11years, remain at the 9095th through 19 years and then return to the 85- 90th percentile at age > 20 years.
Similar to what was found in males, the calculated mean BMI-for-age Z-scores for
females were also positive, demonstrating the mean-BMI-for-age was greater than the 50th
percentile in all age groups. At age groups 24 months – 5 years, 12-19 years and > 20 years,
the difference in BMI for age mean Z-scores between female controls in the general
population was statistically significant demonstrating female SMS individuals have higher
BMIs for their age (p= <0.001, 0.013 and 0.0039, respectively). Although the changes in
percentiles in females with SMS are somewhat less striking than the changes seen in males,
females with SMS age ≥ 20 years were at the 95th -97th BMI percentile, which is the highest
mean percentile among any age group or gender in this cohort.
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If abnormal weight is truly a component of the SMS phenotype, then males and
females would be overweight and often have an obese BMI. The presence of elevated BMIs
and obesity was a main finding in this study. The mean BMI for males’ age ≥ 20 years fell
within the 85th-90th percentile, corresponding to an overweight BMI. BMI for females’ age
≥ 20 fell within the 95-97th percentile, corresponding to an obese BMI. A possible
conclusion for this finding is that females with SMS have higher BMI percentiles than males
with SMS because the prevalence of female obesity in the general population is higher than
the prevalence of male obesity (Ogden et al., 2006).
The depressed linear growth of individuals with SMS in this cohort generally
remains constant throughout the lifespan, as evidenced by a maximum 10th percentile adult
height for SMS males and maximum 5th percentile adult height for SMS females. It appears
that depressed linear growth is a universal feature of the SMS individuals studied in this
cohort and has also been reported by others studying SMS (Edelman et al., 2007).
Obesity in the SMS population
As the prevalence of elevated BMI and obesity continue to increase in the general
population, it is difficult to assess the significance of the obesity present in this SMS
population (Ogden et al., 2006). Over the past twenty years, the prevalence of obese adults
in the general population has doubled while the prevalence of obesity in children has tripled
(Ogden et al., 2006). As of 2004, 32.2% of US adults were obese and 34.1% were
overweight (Ogden et al., 2006). For US children, 16% were overweight and 16% were
obese (Ogden et al., 2008). The data reported in this study demonstrates obesity is present in
this cohort of individuals with SMS. This is evidenced by SMS individuals of all ages
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having negative height-for- age mean z-scores, positive weight-for-age mean z-score thus
leading to positive BMI-for-age mean z-scores.
The prevalence of elevated BMI and obesity in this study population is similar to
rates in the general populations. Figure’s 16 -19 provide a graphical illustration of the
comparison. However, it is important to keep in mind that although the percentage of
obesity in SMS adults is similar to that of the general population, the height of individuals
with SMS are significantly shorter than those of males and females in the general
population. The average height of an adult male is 5’9½”and the average height of an adult
female is 5’4” (Ogden et al., 2004). This is in contrast to the average height of males in this
study of 5’3” and the average height of females in this study of 5’0”.
What is perhaps most striking about the growth data obtained from the parent
questionnaire regarding growth of children and adolescents, is the prevalence of elevated
BMI and frank obesity. In the data obtained from the parent questionnaire, 50% of children
and adolescents were either overweight or obese, compared with 32% of US children and
adolescents within the general population classified as overweight or obese (Ogden et al.,
2008).
The underlying etiology leading to increased BMIs during childhood and adolescents
is not known. Additionally, it is unknown whether or not hyperphagia is the cause of
obesity in SMS or is simply an effect of an underlying biochemical defect that predisposes
individuals with SMS to develop elevated BMIs and obesity. Although it was beyond the
scope of this project, the role of biochemical markers and their association with the
development of obesity should be investigated. Future studies regarding obesity and SMS
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should consider the prospective measurement of biochemical markers known to be
associated with obesity including the following: ghrelin, leptin, insulin, HDL and LDL. A
prospective examination would aid in the determining the time at which elevated BMIs and
obesity occurs in SMS.
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Figure 16. Obesity in US Adults
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Figure 18. Obesity in US Children &
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Part II-Parent Questionnaire
It has been anecdotally reported that obesity is present in individuals with SMS;
however, there is little to no documented evidence of this and no possible explanation for
the cause of this trend. This study hypothesized that if abnormally elevated BMIs are
present in individuals with SMS, hyperphagic behaviors may be involved in this phenotype.
Thus, specific aim two of this study involved the use of a parent questionnaire, including the
validated Hyperphagia Questionnaire (HQ), to explore the role of hyperphagia in individuals
with SMS (Dykens et al., 2007).
The results obtained from the questionnaire portion of this study indicate
hyperphagia and related abnormal food behaviors may be problematic in SMS, as 72% of
parents reported their child had an increased interest in food and 76 % of parents indicated
they had to lock food away from their child. When asked about the frequency of their
child’s night-time food seeking behaviors, three parents indicated that their child no longer
participated in night-time food seeking because the food is now locked and the child is no
longer able to assess it. One parent indicated, prior to locking the kitchen, her child’s nighttime food seeking was constant and her child still continues to frequently hoard food in her
room.
Hyperphagia Questionnaire (HQ)
The HQ was first used to measure hyperphagia in individuals with Prader-Willi
syndrome (Dykens et al., 2007). Hyperphagia is universally present in individuals with
PWS and without intensive dietary monitoring; individuals with PWS will become morbidly
obese (Holm, Cassidy, Butler, Hanchett, Greenswag, & Greenberg, 1993). The underlying
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etiology of obesity in PWS is not definitively known, but it is thought to be caused by
satiety dysfunction (Lindgren et al., 2000).
The HQ is scored on a Likert scale, ranging from 1 to 5. A score of 1 on any given
question equates to the behavior as being “not a problem” and a score of 5 on any given
question equates to the behavior being a “severe and/or frequent problem” (Dykens et al.,
2008). When the HQ was used in the PWS population, the mean scores ranged from 1.80 on
question 4, which asked: “How often does your child forage through the trash for food?” to
4.05 on question 10, which asked: “How clever or fast is your child in obtaining food?” The
majority of the mean scores obtained on the HQ ranged from 2.20-2.24 to 3.06 to 3.34
(Dykens et al., 2007).
In this study, the mean scores obtained on the HQ ranged from 1.28 on question four,
(“How often does your child forage through the trash for food?”) to as high as 3.12 on
question six, (“ How persisent is your child in asking or looking for food when told No?” )
The majority of the mean scores for the questions on the HQ ranged from 2.4 to 2.6,
suggesting that, for the most part, the behaviors assessed for on the HQ were at a minumum,
“somewhat of a problem” for the majority of SMS individuals whose parents’completed the
HQ.
Age and its relationship with hyperphagic tendencies were explored and found not to
be significantly associated with increased hyperphagic behavior, drive or severity. The
absence of a statistically significant association between age and hyperphagic tendencies in
this study is in contrast to the statistically significant positive association between age and
hyperphagic tendencies in the PWS patient population (Dykens et al., 2007.) Although
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statistical significance between age and mean hyperphagic behavior, drive and severity
scores was not reached, age does appear to influence hyperphagic tendencies in SMS. This
is evidenced by individual’s ≥ 20 years of age having the highest mean behavior, drive and
severity scores and individuals in the youngest age category of 6-11 years having the lowest
mean behavior, drive and severity scores. Evidence that supports the hypothesis that
hyperphagic tendencies may increase with age come from the results obtained in Part I of
this study which demonstrates as individuals with SMS age, their BMI’s also increase, even
into the overweight and obese ranges.
Because Dykens et al. considered gender and its relationship to mean hyperphagic
behavior, drive and severity scores in individuals with PWS, the effects of gender were also
examined in this cohort of SMS individuals. Surprisingly, a statistically significant
relationship was found between gender and mean hyperphagic severity scores with females
having higher mean scores when compared to males (p= 0.038). Although not statistically
significant, females also had higher mean behavior and drive scores when compared to
males. No statistically significant relationship was found between gender and mean
hyperphagic behavior, drive or severity scores in the PWS patient population (Dykens et al.,
2007).
Due to differences between gender and age distribution within our study population
when the data for behavior, drive and severity scores were reanalyzed after adjusting age
and gender for each other, stratification by age and gender showed the mean behavior, drive
and severity scores for females were higher than males in all age groups and that females
age ≥ 20 had the highest mean behavior, drive and severity scores. These data confirm
similar published reports of females demonstrating more severe hyperphagic tendencies as
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Edelman et al., (2007) reported “eating/appetite problems” 69.2% of females and only
21.4% of males.
The age of onset of hyperphagia was also considered. Eighteen out of twenty-five
parents (72%) reported their child had an increased interest in food. As the age reported at
which their child showed an increased interest in food spanned from 1 year of age to 34
years of age, it was difficult to pinpoint when exactly increased interest in food began.
However upon closer examination, the majority of parents (55.5%) reported their child
showed at increased interest in food between 1 and 5 years of age, suggesting there may be
an underlying behavioral component involved in the age of onset of increased interest in
food that becomes evident during early childhood. This increase in interest in food may be
related to the fact that prior to around 5 years of age the diet of a child is primarily
controlled by their parent and the increase interest in food may be related to children
becoming more aware of their environment and asserting more control over their food
choices.
As no previous studies have systematically examined the role of hyperphagia in
individuals with SMS, it is unclear if data regarding age of onset of hyperphagia reported in
this study is representative of age of onset of hyperphagia in the SMS population as a whole.
In the use of the HQ in the PWS patient population, the reported mean age of onset of
hyperphagia was 3.5 ± 1.6 years, with a range of 1.5 to 7 years (Dykens et al., 2007). Since
the age of onset of hyperphagia occurs at a younger age in the PWS population, and within a
better defined age range, it appears hyperphagia in SMS may be more variable in severity
and age of onset than in individuals with PWS.
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Another item which was examined separately was the variability in hyperphagic
symptoms. The majority of parents (75%) also felt there was little to no variability in their
child’s interest in food suggesting any preoccupation or interest in food present in their
children with SMS is not affected by outside factors such as stress or emotion. These are
two factors which are well known to effect eating behavior (Geliebter & Aversa, 2003). The
lack of reported variability in their child’s preoccupation with food suggests hyperphagia
may be an inherent component of the SMS phenotype. Similar findings of stable
preoccupation with food in the PWS population also support the notion hyperphagia is an
inherent aspect of the SMS phenotype (Dykens et al., 2007; Holm, Cassidy, Butler,
Hanchett, Greenswag, & Greenberg, 1993).
It appears that foraging through the trash for food is present only in a small
percentage (n=4;16%) of our respondents. It is most likely not present in the high frequency
seen in the PWS patient population. The vast majority of parents, 88%, also felt foodrelated thoughts, talk or behavior had either mild to no interference with their child’s normal
daily routines, self-care, food or work. This suggests the possible negative effects of foodrelated thoughts, talk and behavior are minimal.
The results obtained from the questionnaire portion of this study indicate
hyperphagia or related abnormal food behaviors may be problematic in SMS, as 72% of
parent’s reported their child had an increased interest in food. Perhaps more surprising was
that 76 % of parent’s indicated; when specifically asked, that they had to lock food away
from their child. Not all parents in this study indicated their child had an increased interest
in food, suggesting that although hyperphagia and related abnormal food behaviors are
present in a large portion of SMS individuals examined in this study, hyperphagia may or
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may not be a universal feature of SMS. It is most likely that a combination of numerous
factors including environment, lifestyle as well as a hyperphagia component are involved in
the development of increased BMIs overweight and obesity in individuals with SMS.
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Strengths of Study
The results of Part I of this study provide detailed information on the growth of 78
individuals with SMS. As there is limited information available regarding the growth of
individuals with SMS, the ability to report detailed information on the growth of 78
individuals certainly increases the knowledge of a portion of the SMS phenotype that is less
well known. In comparison to the growth data reported in the medical literature, the
information provided in this study is much more comprehensive and detailed. The large
meta-analysis published by Edelmann et al., in 2007 provided valuable information about
genotype-phenotype information in individuals with SMS but was lacking comprehensive
information regarding growth in individuals with SMS. In over 60% of the cases examined,
information regarding growth and BMI was unavailable. An abstract presented by Smith et
al. in 2004 provided an overview of parametric measurements of height and weight in 54
individuals with SMS. Detailed information regarding BMI was not provided. However, it
was stated that “BMI values were variable across ages” (Smith et al., 2004). Although this
abstract was able to report on how the different height and weight percentile of individuals
with SMS change over time, information regarding the number of individuals in each age
category was not available. This study overcame the limitations described in the two
previous publications by reporting detailed information regarding the height and weight of
78 individuals with SMS. This study was also able to report on how the BMI of 74
individuals with SMS change over time, as there were only 4 individuals in this study who at
last recorded measurement were less than 24 months of age.
Part II of this research project serves as a pilot study, as there is no published
literature which assesses for possible causes of overweight and obesity in individuals with
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SMS. Thus, one of the major strengths of this study is that it is the first to assess the role of
hyperphagia in individuals with SMS as well as its relationship to the presence of elevated
BMIs and obesity. An additional strength of this study is that a validated instrument, the
HQ, was used to assess hyperphagia. The HQ was initially used in the PWS patient
population and was able to quantify the universal aspects of the PWS phenotype related to
hyperphagia. Not surprisingly, the majority of the mean scores on the HQ were lower in the
SMS population compared to the PWS population. A result which was somewhat surprising
was that the mean score on a few of the questions on the HQ were actually higher than the
mean scores in the PWS patient population. These results demonstrate that hyperphagia is
present in SMS and that the HQ was able to capture the hyperphagic characteristics of the
SMS phenotype.
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Limitations
The primary limitation in the chart review used in this study was that the majority of
individuals (61.5%) had only one or two growth measurements available for analysis, and
many were not recent measurements. The lack of multiple growth measurements at similar
time points for each individual possibly limited the ability to truly assess how these
individuals height, weight and BMI change over time. Another possible limitation involves
the growth measurements obtained on the parent questionnaire. Although we are confident
that the height and weight data abstracted from the medical record was collected using
standard procedures, the same cannot be said for the information obtained from parents’ self
report. It is unknown how parents measured their child’s height and weight, and it is
possible the parent did not truly measure their child’s weight, but rather estimated them.
The primary limitation related to the parent questionnaire is the small sample size. It
is possible that due to the small sample size, the results regarding hyperphagia in individuals
with SMS are not truly representative of the SMS population as a whole. It is perhaps
difficult to assess the results of this study in terms of the implications for the SMS
community as a whole, as is the first study designed to specifically assess hyperphagia in
individuals with SMS. Thus, comparisons between previous studies cannot be made. In
addition, the responses on the HQ are taken from parents’ self report of their child’s eating
behaviors. It is well known that parents commonly underestimate the severity of abnormal
behaviors present in their child and the same could possibly be said for the hyperphagic
tendencies assessed for in this study. One potential way to overcome this limitation would
be to administer the HQ to parents of children with SMS as well as other individuals
involved in the child’s life including, physicians, nurses or other care providers and compare
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the results in hopes of obtaining results that are truly representative of the child’s
hyperphagic tendencies. Another potential limitation involves the fact that this
questionnaire was mailed to parents and not administered in person as was the case when the
HQ was used in the PWS population. It is possible parents may have been confused
regarding the meaning of some of the questions on the HQ and may have left that question
blank or answered the question incorrectly. Administering the HQ in person would allow
for discussion regarding the questions on the HQ as well as ensure that every question on the
HQ was answered.
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Future Studies
The finding of females’ age ≥ 20 years of age having the highest mean behavior,
drive and severity scores as well as the highest BMIs, leads us to further consider the
relationship between hyperphagia and elevated BMIs and obesity. An interesting future
study could involve prospective examination of a cohort of males and females with SMS.
The use of a prospective study would provide information on whether or not the
hyperphagia developed first and thus contributed to the development of elevated BMIs and
obesity. It is also possible that elevated BMIs and obesity developed for other reasons and
the presence of hyperphagia in this cohort is simply an effect of the obesity. The use of a
prospective study would also allow for the examination of biochemical markers associated
with obesity including leptin, insulin, HDL and LDL. The prospective examination of
biochemical markers would be able to provide information regarding whether or not
hyperphagia or obesity develops first in SMS.
Another potential avenue to explore for future research would be to re-contact those
parents who indicated their child had an increased interest in food to further investigate this
response. Since there is room for interpretation of “an increased interest in food” targeted
questions would be helpful. A third area for future research would be to re-contact those
parents who indicated they had to lock food away from their child to learn what behaviors
exhibited by their children precipitated the need to lock food away and at what age they
began locking the food away. Knowledge of this information may aid in pinpointing the age
of onset of hyperphagia in SMS so that measures can be taken to control hyperphagia and in
turn hopefully to control elevated BMIs and obesity. It would also be interesting to look
closely at those individuals who, by parent report, had an increased interest in food to see if
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those individuals have higher rates of the negative health consequences known to be
associated with obesity.
A potential research project unrelated to SMS, but still relevant to the topic of
elevated BMIs and obesity, would be to perform a study using the HQ in the general
population. It would be interesting to see how the parents of children without genetic
disorders interpret their child’s food related behaviors, both “normal” and “abnormal” as
well as how the mean behavior, drive and severity scores are different based on weight
status of individuals in the general population.
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Conclusion
The results obtained in Part I of this study demonstrated short stature and a
concomitant increase in weight leading to BMI percentiles in the overweight and obese
range in individuals with SMS. Elevated BMIs were present in both males and females with
SMS, though females tended to have higher BMIs. The results of Part II of this study, the
parent questionnaire, also indicated that hyperphagia was present in individuals with SMS as
evidenced by 76% of parents’ reporting having to lock food away from their child.
The information gained regarding the presence of hyperphagia in individuals with
SMS, as well as the propensity to develop elevated BMIs, provides healthcare professionals
with valuable information regarding a component of the phenotype of SMS which has not
been well described. This increase in knowledge will hopefully enable parents and
caregivers of children with SMS to take preventative measures in order to control any
hyperphagic tendencies present in their child and subsequently prevent the onset of obesity.
Although the severity of hyperphagia present in individuals with SMS does not reach
the levels present in individuals with PWS, as individuals with PWS have died from to
complications related to uncontrolled hyperphagic behaviors, the negative health
consequences of elevated BMIs and obesity are still a concern (Stevenson et al., 2007).
There are currently no dietary or exercise guidelines in place for individuals with SMS. The
results of this study indicating the presence of elevated BMIs and obesity as well as
hyperphagia, may indicate the need for increased dietary monitoring in individuals with
SMS.
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APPENDIX 1: QUESTIONNAIRE
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Please make sure to complete the form to the best of your ability. If you do not wish to
answer a question or are unsure of how to answer, please leave the question blank.

A. DEMOGRAPHIC INFORMATION REGARDING INDIVIDUAL WITH SMITHMAGENIS SYNDROME (SMS)

1.) NAME: ___________________ ____________________
Last
2.) Date of Birth:

First

________ _______ ________
Month

Day

Year

B. DEMOGRAPHIC INFORMATION, To be completed by parent/guardian of the
individual with SMS named above
1.) What is your age? ________
2.) What is your gender?
Male
Female

3.) What is your ethnicity?
White
Black
Hispanic
Native American
Asian
Other, please specify __________________

97

4.) What is your primary language?
English
Spanish
Other

5.) What is your relationship to the child with Smith-Magenis syndrome?
Mother
Father
Step-mother
Step-father
Biological grandmother
Biological grandfather
Other, please specify __________________

6.) What is your current marital status?
Single
Married or living as married
Separated
Divorced
Widowed
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7.) What is the grade of schooling you have completed?
8th grade or less
9th to 11th grade
High School or GED
Some college
Associates Degree (2 yr)
Bachelor’s Degree
Advanced Degree
No formal education

8.) Are you currently employed?
Yes

No

If yes, what is your current occupation? _________________________________
If no, how long have you been unemployed? _____________________________

9.) How many hours a week do you work in your current occupation?
Fewer than 10

20-40 hours

10-20 hours

More than 40 hours

10.) Which comes closest to the current average total annual income for your entire
household before taxes. Please include the income from everyone in your household,
Less than $25,000

$100,000- more

$25,000- $50,999

Prefer not to answer

$51,000-$74,999
$75,000- $99,999
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C. MEDICAL AND SOCIAL HISTORY REGARDING INDIVIDUAL WITH
SMITH-MAGENIS SYNDROME (SMS)
1.) What is your child’s current height?
__________Ft __________in
2.) What is your child’s current weight?
__________lbs
3.) How old was your child when he/she were diagnosed with SMS?
__________ Years __________months

4.) Who made the initial diagnosis of SMS (choose one)?
Primary Care/Pediatrician
Geneticist
Neurologist
Developmental Specialist
Other (Please Specify): ____________________
5.) What were the results of the genetic testing?
17p11.2 deletion
RAI1 mutation
Don’t know

6.) Was your child ever given a diagnosis of failure to thrive (FTT) during infancy?
Yes
Don’t know
No

7.) Did your child ever need to have a feeding tube placed?
Yes
Don’t know
No

100

8.) If yes, (that your child had a feeding tube) did he/she have a g-tube placed surgically?
Yes
Don’t know
No

9.) Was your child born with or diagnosed with any of the following?
Cleft lip

Yes

No

Kidney defect

Yes

No

Cleft palate

Yes

No

Urinary tract defect

Yes

No

Heart defect

Yes

No

Low thyroid function

Yes

No

10.) Has your child ever taken medication for any of the following?
Heart Defects
No

Yes

No

Anxiety

Yes

Seizures
No

Yes

No

Depression

Yes

Diabetes
No

Yes

No

Hyperactivity/ADD

Yes

High cholesterol
No

Yes

No

Sleep Disturbances

Yes

High blood pressure
No

Yes

No

Self-injurious behavior

Yes

Thyroid problems
No

Yes

No

Aggression

Yes

Kidney problems
No

Yes

No

Obsessive compulsive behaviors

Acid reflux
No

Yes

No

Kidney reflux

Yes
Yes
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11.) Has your child ever taken any medications that have affected his/her appetite, weight or
activity level? If yes, please list the medication and circle the appropriate effect:

Medication
Name

Change in Weight

Change in Appetite

Change in Level of
Physical Activity

(please list)
Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

Increase

Decrease

12.) Is there a family history of any of the following? Please check all that apply:
Overweight
Obesity
Hypertension
Diabetes
Pre-diabetes
High cholesterol
Heart disease
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For questions 13-15, please check just one box for each question.
13.) Where does your child with SMS currently live?
At home
In a group home/assisted living facility
Other, please specify _________________

14.) What is the highest level of schooling that your child has completed?
Elementary school
Middle school
High school
15.) Did your child receive assistance in school?
Yes
No
C. EXERCISE HISTORY:
1.) Does your child have an exercise program/physical activity program?
Yes
No
My child:
walks/runs

___ times per week

for ____ minutes each time

___ times per week

for ____ minutes each time

plays outside ___ times per week

for ____ minutes each time

rides bicycle ___ times per week

for ____ minutes each time

swims

other (please list below)
___________ times per week

for ____ minutes each time

____________ times per week

for ____ minutes each time

2.) My child is able to exercise but he/she does not have a regular routine:
Yes

No
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3.) My child is unable to exercise due to:
Severe joint pain
Shortness of breath
Scoliosis
Muscle weakness
Will not participate in physical activity
Other, please specify ________________________________________
____________________________________________________________

D. DIETARY HISTORY:
1.) Do you consider your child to have a daily eating pattern similar to other children his/her
age?
Yes
No
2.) Which meals does your child eat each day? Please check all that apply
Breakfast
Lunch
Dinner
Snacks

3.) Do you feel your child eats:
Less than normal amounts of food
Normal amounts of food
Greater than normal amounts of food
4.) Does your child binge eat?
Yes

No

5.) Does your child snack?
Yes

No

6.) Does your child eat/snack just before bedtime?
Yes
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No

7.) What are your child’s top 3 favorite snacks?
________________________________
________________________________
________________________________

8.) How often does your child wake up during the night?
0-1 times per night
2-3 times per night
4-5 times per night
> 5 times per night
9.) Of the times that your child wakes up during the night, how often does he or she eat?
Never
Rarely
Occasionally
Always
10.) Do you ever or have you ever had to lock food away from your child?
Yes
No
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11.) How upset does your child generally become when denied a desired food?
Not particularly upset at all
A little upset
Somewhat upset
Very upset
Extremely upset

12.) How often does your child try to bargain or manipulate to get more food at meals?
A few times a year
A few times a month
A few times a week
Several times a week
Several times a day

13.) Once your child has food on their mind, how easy is it for you or others to re-direct
your child away from food to other things?
Extremely easy, takes minimal effort to do so
Very easy, takes just a little effort to do so
Somewhat hard, takes some effort to do so
Very hard, takes a lot of work to do so
Extremely hard, takes sustained and hard work to do so
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14.) How often does your child forage (look/search) through the trash for food?
Never
A few times a year
1–2 times a month
1–3 times a week
4 to 7 times a week

15.) How often does your child get up at night to food seek?
Never
A few nights a year
1–2 nights a month
1–3 nights a week
4 to 7 nights a week

16.) How persistent is your child in asking or looking for food after being told “no” or “no
more”?
Lets go of food ideas quickly and easily
Lets go of food ideas pretty quickly and easily
Somewhat persistent with food ideas
Very persistent with food ideas
Extremely persistent with food ideas

17.) Outside of normal meal times, how much time does your child spend talking about
food or engaged in food-related behaviors?
Less than 15 minutes a day
15 to 30 minutes a day
30 minutes to an hour
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1 to 3 hours a day
More than 3 hours a day

18.) How often does your child try to steal (take when told not to) food (that you are aware
of?)
A few times a year
A few times a month
A few times a week
Several times a week
Several times a day

19.) When others try to stop your child from talking about food or engaging in food-related
behaviors, it generally leads to:
No distress or upset
Mild distress or upset
Moderate distress or upset
Severe distress or upset
Extreme distress, behaviors can’t usually be stopped

20.) How clever or fast is your child in obtaining food?
Not particularly clever or fast
A little clever or fast
Somewhat clever or fast
Very clever or fast
Extremely clever of fast
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21.) To what extent to food-related thoughts, talk, or behavior interfere with your child’s
normal daily routines, self-care, school, or work?
No interference
Mild interference; occasional food-related interference in completing school,
work, or hygiene tasks
Moderate interference; frequent food-related interference in completing school,
work, or hygiene tasks
Severe interference; almost daily food-related interference in completing school,
work, or hygiene tasks
Extreme interference, often unable to participate in hygiene tasks or to get to
school or work due to food-related difficulties

22.) How old was your child when he/she first showed an increased interest in food?
___ years
My child does not have an increased interest in food

23.) How variable is your child’s preoccupation or interest in food?
Hardly ever varies
Usually stays about the same
Goes up and down occasionally
Goes up and down quite a lot
Goes up and down all the time
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